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ABSTRACT 
 
CHARACTERIZATION OF B CELL DEVELOPMENT AND ACTIVATION IN THE 
ABSENCE OF AKT OR PRESENILIN 
Marco Calamito 
David M. Allman, Ph.D. 
The biochemical pathways critical to B cell development remain poorly defined.  
Here I characterize a critical role for two separate families of proteins, Akt and 
Presenilin in the development and activation of B cells.  The absence of Akt1 and 
Akt2 leads to a block in marginal zone (MZ) and B1B cell development, as well 
as decreased cellularity of splenic follicular B cells.  In addition, I find the 
combined loss of Akt1 and Akt2 causes altered B cell receptor repertoire and 
poor competitive ability when matched against wild-type B cells.  Similar to 
deficiencies in the Akt pathway the combined loss of Presenilin1  and Presenilin2 
results in defective MZ, B1B cell development, and altered BCR repertoire 
selection.  Furthermore, I find that these defects are independent of the Notch 
pathway and that Presenilins are required for optimal responses to cross-linking 
of the BCR.  Collectively, these findings identify and phenotypically characterize 
two novel pathways important to B cell development and function. 
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Chapter 1: INTRODUCTION 
 
1.1 Overview 
A diverse array of microorganisms present a constant threat to the survival of 
higher order animals.  The short reproductive cycle of microorganisms endows 
these potential pathogens with the ability to rapidly mutate and evolve 
mechanisms to evade host clearance.  Mammalian evolution’s answer to the 
threat posed by bacteria, virus, fungi, and parasites is a complex and multi-
faceted immune system.  Both innate and adaptive mechanisms combine to 
ensure host survival and reproduction.  
 As part of adaptive immunity, the humoral immune response is mediated 
by antibody producing B cells, capable of recognizing an infinite number of 
foreign antigens and providing both short and long term protection to pathogenic 
challenge.  A growing body of literature suggests that there is a division of labor 
within the B cell lineage such that specific subpopulations distinguished by 
surface marker expression, activation state and physiological function are 
required to combat particular subsets of pathogens at different time points during 
the course of infection (Martin, Oliver et al. 2001; Lopes-Carvalho, Foote et al. 
2005; Baumgarth, Choi et al. 2008).  These B cell populations can be divided in 
two distinct groups B1 and B2, with the B2 subset further divided into follicular 
(FOL) and marginal zone (MZ) B cells.  FOL B cells make up the overwhelming 
majority of B-lymphocytes in the mouse, and cooperate with T-cells to form 
germinal centers eliciting highly specific responses to protein antigens.  While 
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this function may be critical to the survival of the host, primary FOL B cell 
responses take on the order of five to seven days to become firmly established 
(Jacob, Kassir et al. 1991).  It is the responsibility of the innate immune system to 
protect the host during this lag phase of the humoral response.  MZ and B1 B 
cells generate their B cell receptors (BCR) through recombination of 
immunoglobulin (Ig) genes and are firmly established in the adaptive arm of the 
immune system, yet examination of their function and role in the immune 
response demonstrates an “innate-like” quality.  MZ and B1 B cells generate 
short lived plasma cells with much faster kinetics than do FOL B cells (Martin, 
Oliver et al. 2001).  Furthermore, the nature of the antigen that MZ and B1 B cells 
respond to is often a non-protein, such as conserved glycolipids or carbohydrate 
motifs found on the majority of pathogenic organisms (Kearney 2005).  It is 
thought, that the ability of these innate-like B cells to recognize and secrete large 
quantities of antibody towards these common microorganism components 
“bridges the gap” between the early innate immune response and late adaptive 
immune response (Martin and Kearney 2002).   
 Although MZ and B1 B cells exhibit innate like functions and make up only 
a small percentage of the total B cell pool, their development requires a complex 
array of molecules and signaling pathways activated by the BCR.  A central 
feature of B cell development is the requirement to purge the BCR repertoire of 
auto-reactive clones (negative selection).  In addition to negative selection, 
developing B cells must generate clones with sufficient BCR signaling capacity to 
ensure survival i.e. positive selection/tonic signaling.  Of particular importance to 
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this complex and poorly defined process, is the lipid kinase phosphoinositide 3-
kinase (PI-3K).  Indeed, mice deficient in the catalytic subunit of PI-3K, p110δ, 
fail to develop MZ or B1 B cells while maintaining a FOL B cell pool albeit with 
decreased numbers (Clayton, Bardi et al. 2002).  PI-3K signaling is a 
downstream target of multiple receptors including antigen, cytokine, and 
chemokine receptors, including B cell activating factor (BR3), and Notch 
receptors.  (Okkenhaug, Ali et al. 2007; Cardoso, Girio et al. 2008; Woodland, 
Fox et al. 2008).  Recent work has shown that active PI-3K is sufficient to rescue 
B cells development and maintenance in the absence of a surface BCR 
(Srinivasan, Sasaki et al. 2009).  A critical downstream effector of PI-3K is the 
serine/threonine kinase Akt.  While recent studies have elucidated a function for 
Akt in T cell development (Juntilla, Wofford et al. 2007; Mao, Tili et al. 2007) the 
role of Akt signaling in the development and activation of B cells remains 
undefined.   
 The data and analysis in Chapter 3 characterizes B cell development in 
the combined absence of Akt1 and Akt2, revealing defective peripheral B cell 
development, including dramatic decreases in MZ and B1 B cell compartments, 
reminiscent of the phenotype observed in PI-3K deficient models (Fruman 2004).  
These observations suggest that Akt is a major and required target of PI-3K 
signaling in B cell biology.  In addition, I demonstrate that Akt1/2 deficient FOL B 
cells are poor competitors when mixed with wild-type cells in-vivo and exhibit 
defective proliferation to various stimuli in-vitro.  Furthermore, the defective MZ B 
cell compartment observed in the absence of Akt1/2 is not rescued by enforced 
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expression of the pro-survival molecule B-cell lymphoma-extra large (Bcl-xL). 
Finally, I examine the potential connection between Notch and Akt in MZ B cell 
development.   
 In Chapter 4, I expand upon earlier work performed in this lab 
demonstrating crosstalk between the BCR and Notch and ultimately uncover a 
Notch independent function for the γ-secretase complex and it’s catalytic subunits 
Presenilin 1 (PS1) and Presenilin 2 (PS2) in B cell development and activation.  
In sum, my work contributes to our understanding of the factors controlling B cell 
biology by further defining the molecules critical to B cell development, activation, 
and BCR repertoire formation. 
 
1.2 Mature peripheral B cell subsets: phenotype and function 
Naive mature B lymphocytes are classically divided based upon surface marker 
expression and function into one of three distinct populations; follicular (FOL), 
marginal zone (MZ) and B1 B cells (Fig 1).  Together these subsets form the 
cellular foundation of the humoral immune response, allowing protection to a 
wide array of antigens.   
 
1.2.1  Follicular B cells 
The adult mouse spleen contains roughly 30 million B cells, the majority of which 
are small long lived (~4.5months) re-circulating FOL B cells (Lopes-Carvalho and 
Kearney 2004).  FOL B cells reside in the follicle of the lymph node and spleen, 
adjacent to T cell zones enabling these two populations to interact at the 
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interface betIen the two areas during a thymus dependent (TD) response (Pillai 
and Cariappa 2009).  Antigen receptor stimulation of FOL B cells in conjunction 
with T cell help leads to proliferation, plasmablast formation and the eventual 
formation of a germinal center where somatic hypermutation and isotype 
switching occur.  (Benson, Erickson et al. 2007).  These processes result in the 
generation of affinity matured long lived plasma and memory cells conferring 
immunity to future exposure with that antigen.   
 
1.2.2 Marginal Zone B cells 
In contrast to FOL cells MZ B cells inhabit a distinct anatomical niche located 
between the red and white pulp of the spleen. It is here that arterial blood 
empties into the marginal sinus and is filtered by resident cells including 
macrophages, dendritic and MZ B-cells.  Thus, MZ B cells are uniquely 
positioned to contact blood borne pathogens (Lopes-Carvalho and Kearney 
2004).  Indeed, mice lacking MZ B-cells succumb to streptococcus pneumoniae 
within days of infection (Tanigaki, Han et al. 2002).  Interestingly, MZ B-cells 
express higher basal levels of the activation markers CD80, CD86, and MHC 
class II.  In addition, MZ B-cells are more effective antigen presenting cells than 
FOL B-cells, inducing robust T-cell responses (Attanavanich and Kearney 2004).  
MZ-B cells were long thought to be sessile, and while it remains true that these 
cells do not exit the spleen, recent evidence shows that MZ B-cells are highly 
motile, migrating every few hours from the marginal sinus area to the B-cell 
follicle (Cinamon, Matloubian et al. 2004; Cinamon, Zachariah et al. 2008).  
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Despite representing only five percent of the splenic B cell pool, MZ cells along 
with B1 cells dominate early humoral immune responses to T-independent 
antigens (Martin, Oliver et al. 2001).  In addition, MZ B-cells are hyper-
responsive to toll-like receptor (TLR) stimuli, and upon activation quickly 
differentiate into IgM secreting plasma cells (Oliver, Martin et al. 1997).  
(Functional differences summarized in Table 1).  These observations have lead 
to a model in which MZ and B1 B cells function to bridge the gap from the early 
humoral response to the late affinity matured FOL B-cell dominated response. 
Finally, FOL and MZ B-cells differentially express surface IgM, the complement 
receptor CD21/35, and low affinity IgE receptor CD23, enabling identification 
through flow cytometric based strategies summarized in Table 2. 
 
1.2.3 B1 B cells   
B1 B cells are highly enriched in peritoneal and pleural cavities, contribute to T-
independent responses, and can be subdivided based on expression of the 
surface marker CD5 into CD5+ B1a and CD5- B1b B cells.  B1a B cells 
spontaneously secrete IgM providing a first line defense against encapsulated 
bacteria, and are thought to provide a more innate like function (Haas, Poe et al. 
2005).  B1b cells can be rapidly induced to secrete antibody to T-independent 
antigens helping to clear pathogen and aid in long term immunity (Alugupalli, 
Leong et al. 2004).  As mentioned above, B1 and MZ B cells tend to express 
BCRs that recognize conserved components found on microorganisms.  
Interestingly, many B1 B cells lack N-additions, and thus possess germ-line 
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encoded antigen receptors that afford protection against a wide range of 
pathogens (Feeney 1990; Gu, Forster et al. 1990).  For example B1 B cells are 
enriched for a VHVL pair with specificity for phosphocholine (T15 idiotype), a 
common component of bacterial cell walls (Gu, Forster et al. 1990; Feeney 
1991).  Adoptive transfer of T15 antibody affords passive immunity to 
streptococcus pneumoniae (Briles, Nahm et al. 1981).  These observations imply 
that germ-line encoded BCRs have an innate-like ability to recognize microbial 
products and as such could be selected for during evolution. 
 In contrast to the accepted role for B1 cells in the early humoral response, 
the development of these cells is anything but clear.  Two models have been 
advanced to explain the ontogeny of the B1 compartment, the lineage model and 
the selection model (Dorshkind and Montecino-Rodriguez 2007).  The lineage 
model is based upon the observation that fetal liver progenitors are best able to 
reconstitute the B1 compartment when compared to adult marrow progenitors, 
and that B1 cells possess the capacity for self-renew (Kantor, Stall et al. 1992; 
Kantor, Stall et al. 1995; Montecino-Rodriguez, Leathers et al. 2006).  The 
enhanced ability of fetal progenitors to form B1 B cells is perhaps the result of 
ligand/cytokine variations in fetal vs. adult B cell development that influence 
expression of genes important to the B1 fate such as terminal deoxynucleotidyl 
transferase (TdT).   
 In contrast, the selection model proposes that both the B1 and B2 lineage 
share a common precursor cell, and signals derived from the BCR will direct cell 
fate (Pennell, Mercolino et al. 1989; Arnold, Pennell et al. 1994; Lam and 
 8 
Rajewsky 1999).  This notion is supported by data demonstrating that B2 cells 
can be induced to up-regulate surface expression of the B1 marker CD5 upon 
BCR cross-linking (Wortis, Teutsch et al. 1995).   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Table 1:  Characteristics of naïve mature B cell populations 
Functional 
Characteristics 
FOL MZ B1 
Localization 
 
Spleen 
Lymph Node 
Bone Marrow 
 
Spleen 
 
Peritoneal Cavity 
Spleen 
T Independent 
Response 
Weak Strong Strong 
T Dependent 
Response 
Strong Weak  
BCR Response Proliferation Death Death 
TLR-Ligand Response 
Mild 
Proliferation 
Strong 
Proliferation 
Strong 
Proliferation 
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Table 2:  Surface marker expression of murine B cell subsets 
Tissue Cell Surface Marker 
Bone Marrow CD19 B220 CD43 AA4 IgM 
Pro-B + + + + - 
Pre-B + + +/- + - 
Immature B + + - + + 
Mature B + + - - + 
      
Spleen CD19 CD23 CD21/35 AA4 IgM 
Transitional 1 + - +/- + +++ 
Transitional 2 + + + + +++ 
Transitional 3 + + ++ + ++ 
MZP + + +++ +/- +++ 
FOL + + ++ - ++ 
MZ + - +++ - +++ 
      
Peritoneal 
Cavity 
CD19 B220 CD43 CD5 IgM 
B1a + +/- + + +++ 
B1b + +/- + - +++ 
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Figure 1:  Gating scheme for flow cytometric analysis of murine B cell subsets. (A) 
Flow cytometric analysis of BM cells from c57/B6 mice aged 12  weeks. The left-most plots 
are gated on viable donor-derived (DAPI- Ly5B6+) cells. Numbers in plots indicate the 
frequency of events in the indicated gate as a function of the indicated parent population. 
Pro-B, CD43+ B220+ CD19+ AA4+; pre-B, CD43low B220+ IgM- AA4+; immature B, CD43- 
B220+ IgM+ AA4+; mature B, CD43- B220+ IgM+ AA4-.  (B)  Fr.I, IgM+++CD21/35+, Fr.II 
IgM++CD21/35++, Fr.III IgM+++ CD21/35+++, (T1 CD23- AA4+) (T2 CD23+ AA4+)  (T3 CD23+ 
AA4+)  (FOL CD23+ AA4-) (MZP CD23+ AA4+/-)  (MZ CD23- AA4-).  (C)  B2 CD43- B220+; B1 
CD43+ B220Int-Low; within in B1 gate B1a (CD5+)  B1b(CD5-).  
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1.3 B cell development 
1.3.1  B cell development in the bone marrow 
Peripheral B cell compartments derive from B-lineage committed precursors 
resident in the liver during fetal life, and then in the bone marrow of adult mice.  
Precursors expressing high levels of the early B cell factor (EBF) restrict lineage 
potential and in conjunction with Pax-5 commit progenitors to the B cell fate 
(Cobaleda, Schebesta et al. 2007; Pongubala, Northrup et al. 2008). 
Early B cell populations in the bone marrow sequentially transit a series of 
phenotypically distinct stages consisting of pro, pre, and immature B cell pools.  
Each of these populations can be defined by differential expression of surface 
markers consisting of CD19, B220, CD43, AA4 and IgM (Hardy, Li et al. 2000), 
[see Table 2 and Fig 1 for surface marker classification scheme]. These early 
precursors initiate expression of recombinase-activating genes (RAG), undergo 
rearrangement of germline encoded diversity (D) and joining (J) Ig heavy chain 
genes.  Active rearrangement of variable (V) heavy chain genes marks pro-B 
cells (Nemazee 2006).  In frame recombination of VH with existing DHJH gene 
segments will lead to expression of an intact Ig heavy chain, which pairs with a 
surrogate light chain (SLC) to form a pre-BCR.  The pre-BCR signals through Ig-
α and Ig-β resulting in a rapid decrease in RAG protein levels and cessation of 
heavy chain rearrangement (Jung, Giallourakis et al. 2006).  Cells at this stage 
also grow in size and undergo an intensive proliferative burst.  B cells deficient in 
the ability to successfully generate or transmit signals through the pre-BCR, as is 
the case in RAG, Igα, or Igβ deficient mice are blocked at this early stage of B 
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cell development (Herzog, Reth et al. 2009).  These observations underscore the 
fundamental importance the Ig heavy chain plays in the survival of the earliest B 
cells.   
As cells exit cell cycle and conclude the massive wave of proliferation 
sparked by pre-BCR signaling, CD43 expression is decreased and the RAG 
proteins are re-expressed.  At this stage Ig light chains commence 
rearrangement.  Two different clusters of Ig genes are capable of generating light 
chains, the kappa (κ) and lambda (λ) loci.  Light chain rearrangement proceeds 
in an ordered fashion with the κ-locus preceding the λ-locus.  Productive 
rearrangement and pairing of heavy and light chain leads to surface expression 
of a mature BCR in the form of IgM.  Surface IgM expression defines entry into 
the immature stage of bone marrow B cell development.  It is at this stage that 
the BCR specificity of each respective B cell clone is first screened for auto-
reactivity.  Clones with BCRs recognizing multivalent self-antigens undergo 
clonal deletion or receptor editing (Nemazee and Burki 1989; Hartley, Crosbie et 
al. 1991).  Recent work has demonstrated that, for membrane bound self 
antigens, receptor editing is the dominant mechanism by which auto-reactive 
specificities are purged from the immunoglobulin repertoire (Halverson, Torres et 
al. 2004).  Clones possessing weak reactivity to self or recognizing soluble 
antigens are capable of reaching peripheral B cell compartments, but these cells 
are nonfunctional (anergic) with high turnover rates if matched against wild-type 
competitors (Cyster, Hartley et al. 1994).  Consequently, though the adult murine 
bone marrow produces roughly 15 million immature B cells per day, only 10% of 
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these cells leave the bone marrow (Allman, Ferguson et al. 1993; Rolink, 
Andersson et al. 1998).  The short half-life of immature B cells and extended life 
span of mature B cell compartments implies tremendous selective pressure is 
placed on immature B cells, and show active negative selection in B cell 
development.  Those rare clones that successfully transit negative selection in 
the bone marrow are able to home via the blood to peripheral lymphoid organs 
such as the spleen.   
 
1.3.2 Peripheral B cell development in the spleen 
Immature B cells in the spleen are termed transitional cells;  phenotypically these 
cells are subdivided into three distinct subsets based on termed transitional 1 
(T1), transitional 2 (T2), and transitional 3 (T3).  These cell types are 
differentiated based on differential surface expression of AA4, CD23, IgM and 
CD21/35 (see table 2, Fig1/2).  The majority of transitional B cell in the spleen of 
an adult mouse will give rise to mature FOL B cells, and a minor fraction of 
transitional cells will transit through a marginal zone precursor (MZP) stage of 
development en route to a mature MZ B cell (Fig 2). Functionally, these cells are 
defined by their rapid turnover and apoptotic response to BCR cross-linking.  
Transitional B cells respond to TLR agonists and CD40 receptor cross-linking, 
demonstrating these cells are capable of proliferating to certain stimuli (Allman, 
Ferguson et al. 1992). The BCR mediated cell death that transitional B cells 
experience is in part due to defective generation of nuclear factor kappa-light-
chain enhancer of activated B cells (NF-κB) targets A1 and Bcl-xL (Castro, Wright 
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et al. 2009).  The rapid cell turnover and apoptotic BCR response suggest that 
transitional B cell populations are also actively undergoing negative selection, 
purging auto-reactive specificities from the developing B cell pool and ensuring a 
self tolerant mature B cell compartment.  However, there is a growing body of 
evidence demonstrating the importance of BCR specificity in positive selection to 
the B1, MZ or FOL B cell compartments.  
 The notion that positive selection exists for B cells, is supported by a 
landmark study demonstrating that the BCR is required for the survival and 
persistence of mature B cell populations (Lam, Kuhn et al. 1997).  This work was 
later extended to show a requirement for BCR signaling in of itself for proper B 
cell maintenance (Kraus, Alimzhanov et al. 2004).  In addition, light chain V gene 
segments while diverse in the pre-B and transitional pools, are skewed towards 
certain V genes in the mature compartment (Gu, Tarlinton et al. 1991; Levine, 
Haberman et al. 2000), implying both positive and negative selective pressure on 
certain VH VL pairs.  Furthermore, evidence for B cell positive selection was 
substantiated by the observation that B cells specific for the Thy-1 glycoprotein, a 
self antigen, can be selected into the B1 compartment in normal mice and into 
the MZ B cell pool in mice expressing low levels of Thy-1 (Hayakawa, Asano et 
al. 1999; Wen, Brill-Dashoff et al. 2005).  These studies imply that BCR 
specificity, and perhaps signal strength play a role in the B1, MZ or FOL cell fate 
decision of those cells gaining access to long lived B cell pools.   
 Casola et al demonstrated that stronger BCR signals lead to the 
generation of B1, while weaker BCR signaling was conducive to formation of MZ 
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and FOL B cell populations (Casola, Otipoby et al. 2004).  In addition, while the 
FOL B cell compartment is intact, albeit compromised, in mice deficient in 
molecules critical to BCR signaling such as Bruton’s tyrosine kinase (Btk) or 
CD19, these cells fail to compete with wild-type B cells in mixed marrow 
chimeras (Sprent and Bruce 1984; Otero, Anzelon et al. 2003)  These 
observations suggest that the “fitness” of a BCR is sensed through transient 
interaction with self ligands and/or tonic BCR signaling, and that this in turn 
governs the make up of the B cell pool.   
A key receptor that works in concert with the BCR to maintain the 
peripheral B cell repertoire is the B cell-activating factor receptor (BR3), 
expressed on FOL, MZ, and late transitional cells and it’s ligand B lymphocyte 
stimulator (Blys) (Moore, Belvedere et al. 1999; Harless, Lentz et al. 2001).  Mice 
deficient in BR3 or in Blys have decreased MZ and FOL B cell numbers that can 
be partially rescued by enforced expression of the pro-survival molecule Bcl-xL 
(Lentz, Cancro et al. 1996; Lentz, Hayes et al. 1998; Batten, Groom et al. 2000; 
Harless, Lentz et al. 2001; Amanna, Dingwall et al. 2003).  Interestingly, BR3 
signaling is not required for the generation or survival of B1 B cells (Lentz, Hayes 
et al. 1998).  Recent studies by Stadanlick et al. have established a molecular 
mechanism of BCR-BR3 cross-talk (Stadanlick, Kaileh et al. 2008).  This work 
demonstrates that tonic signaling through the BCR generates the classical NFκB 
target p100, p100 then serves as a substrate for processing by BR3 leading to 
increased expression of pro-survival molecules Bcl-xL and Pim2; thus regulating 
peripheral B cell numbers.  These observations support the notion that BCRs are 
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not only screened for auto reactivity, but also for “fitness” as assayed by the 
ability to generate p100.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  Peripheral B cell subsets and development.  Immature B cells from the 
bone marrow enter the spleen (top) via the blood and are termed Transitional (T1 and 
T2)  T2 B cells mature into either the follicular (FOL) or marginal zone (MZ) fates.  
This decision is dictated in part by BCR signal strength.  MZ development requires 
CD19/PI-3K, Notch2, and Blys whereas normal FOL development requires Blys.  B1 
B cells home to the peritoneal cavity (bottom) and are most efficiently generated 
during fetal life.  Some immature B-cells harbor BCRs of sufficient BCR signal 
strength to drive the B1 B cell fate.  B1s can be further subdivided into the B1a or B1b 
lineage. 
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1.4 BCR signaling pathways and the importance of PI-3K. 
 Though a wealth of knowledge regarding the signaling pathways activated 
downstream of the BCR exists, questions remain regarding the how these 
effectors are utilized in the context of B cell development and peripheral B cell 
fate decisions.  The BCR signaling complex is composed of membrane bound 
IgM associated with the signal transducing Igα-Igβ heterodimer (Tolar, Sohn et 
al. 2008).  BCR aggregation leads to the recruitment of numerous kinases, 
adaptors, and lipid modifying enzymes that serve to propagate activation signals 
to downstream secondary effectors.  A key molecule in this signaling cascade is 
the lipid modifying enzyme phosphoinositide 3-kinase (PI-3K).  PI-3K 
phosphorylates the inositol group of phosphatidylinositol (4,5)-bisphosphate 
(PIP2) to form phosphatidylinositol (3,4,5)-trisphosphate (PIP3).  BCR 
oligermerization leads to rapid PI-3K recruitment via the B cell cytoplasmic 
adaptor protein (BCAP).  PI-3K proceeds to generate PIP3 which can serve as a 
docking site at the plasma membrane for pleckstrin homology (PH) containing 
proteins  (Fruman 2004).  Molecules such as Btk and phospholipase C gamma 2 
(PLCγ2) are recruited through their PH domains to the plasma membrane where 
they are phosphorylated by spleen tyrosine kinase (Syk) or other receptor 
associated tyrosine kinases.   Activated Btk phosphorylates PLCγ2 leading to 
increased generation of the secondary messengers inositol triphosphate (IP3) 
and diaglycerol (DAG) (Watanabe, Hashimoto et al. 2001).  These molecules 
then activate calcium mobilization and protein kinase C (PKC) respectively, 
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leading to the activation of NFκB and nuclear factor of activated T cells (NFAT) 
transcription factor families (Fig 3) (Scharenberg, Humphries et al. 2007). 
 There exist three different classes of PI-3K molecules. In cells of the 
immune system class I family members are the best characterized.  Class I PI-3K 
molecules consist of a catalytic subunit that carries out generation of PIP3 from 
PIP2, referred to in general terms as p110.  Of the three p110 isoforms (p110α, 
p110β, p110δ) p110δ is highly expressed and is the best characterized catalytic 
subunit in lymphocytes.  Catalytic subunits pair with an adaptor termed p85, 
capable of binding to BCAP and localizing PI-3K at the plasma membrane 
(Okkenhaug and Vanhaesebroeck 2003).  PI-3K activity is opposed by 
phosphatase and tensin homolog deleted on chromosome 10 (PTEN), an 
enzyme that converts PIP3 into PIP2 (Suzuki, Kaisho et al. 2003).   
 Deletion of the p110δ subunit from the B-lineage results in a block in the 
generation of MZ and B1 B cells, FOL B cell numbers in the spleen are 
decreased, in addition, in-vitro proliferative responses to BCR cross-linking are 
diminished (Clayton, Bardi et al. 2002; Okkenhaug, Bilancio et al. 2002).  Loss of 
p85 results in decreases in cellularity for transitional and mature populations, but 
an increase in pro-B cells suggesting a bottleneck in development (Fruman, 
Snapper et al. 1999; Suzuki, Terauchi et al. 1999).  Interestingly, while Btk is a 
target of PI-3K signaling, the phenotype of p85α-Btk double deficient B cells is 
more severe than deletion of either p85α or Btk alone, suggesting Btk 
independent phenotypes associated with the loss of PI-3K activity.  (Donahue, 
Hess et al. 2004).  
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 Co-ligation of the BCR and it’s co-receptor CD19 enhances recruitment of 
PI-3K to the plasma membrane and decreases the threshold for BCR activation 
by 100 fold (Carter and Fearon 1992).   Deletion of CD19 from mice results in an 
overlapping phenotype with PI-3K deficient B cells, mainly loss of MZ and B1 B 
cells, and an inability to compete with wild-type progenitors in mixed marrow 
chimeras (Rickert, Rajewsky et al. 1995; Otero, Anzelon et al. 2003). 
Interestingly, mice deficient in PTEN exhibit increased B1 and MZ B cell 
numbers, and crossing PTEN deficient mice onto a CD19 deficient background 
partially rescues MZ development (Anzelon, Wu et al. 2003).  Furthermore, 
immature B cells deficient in PTEN do not undergo apoptosis in response to BCR 
cross-linking, and in contrast to wild-type cells proliferate  (Browne, Del Nagro et 
al. 2009).  Recent work by Srivinson et al. demonstrated that expression of an 
activated form of PI-3K was sufficient to rescue survival of mature B cells in 
which the BCR was conditionally deleted (Srinivasan, Sasaki et al. 2009).  These 
observations highlight the importance of the PI-3K signaling pathway and its 
downstream effectors in BCR signaling and B cell biology.  One major target of 
PI-3K activation is the Akt pathway, to date the direct role of Akt in B cell 
development and activation remains undefined. 
 
1.5  The PI-3K target Akt 
 Oligimerization of the BCR in-vitro leads to transient activation of the Akt 
pathway.  Coordinate co-ligation of the BCR and CD19 results in enhanced and 
prolonged activation of the Akt pathway (Otero, Omori et al. 2001).  Akt, also 
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known as protein kinase B (PKB) is expressed in three distinctly coded isoforms, 
Akt1, Akt2, Akt3. All three Akt isoforms display similar structure and are 
recruited/activated via their PH domain by PI-3K activity (Plas and Thompson 
2005; Franke 2008).  Akt1 is ubiquitously expressed, Akt2 expression is largely 
restricted to the pancreas and liver, and Akt3 expression is limited to the neural 
tissue (Juntilla and Koretzky 2008).  Deletion of Akt1 causes a dwarf phenotype, 
in which mice on average are 20% smaller then wild-type aged matched controls 
(Cho, Thorvaldsen et al. 2001).  Deficiency in Akt2 leads to Insulin resistance 
and a diabetes mellitus-like syndrome (Cho, Mu et al. 2001).  Mice deficient in 
Akt3 are grossly normal, though brain size is reduced 20% (Easton, Cho et al. 
2005).  The combined loss of Akt1 and Akt2 results in neonatal lethality (Peng, 
Xu et al. 2003).  Akt signaling regulates a diverse array of cellular outcomes 
including metabolism, proliferation, and survival (Figure 3) (Manning and Cantley 
2007).  In addition to BCR mediated activation, Akt is downstream of BR3 leading 
to enhanced metabolic fitness.  (Patke, Mecklenbrauker et al. 2006; Otipoby, 
Sasaki et al. 2008).  The relative importance of Akt in the metabolic fitness and 
survival of B cells downstream of signaling mediated by BR3, remains poorly 
defined. 
Two recent papers characterized thymocyte development in the absence 
of Akt signaling. Collectively this work demonstrated a profound defect at the β-
selection checkpoint, a stage in which the T cell receptor (TCR) beta chain 
undergoes VDJ recombination to generate a pre-TCR and is required for 
subsequent proliferation and differentiation of early thymocytes.  Progenitors 
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deficient in Akt1 and Akt2 showed an increased propensity for apoptosis after 
TCR activation, leading to a paucity of mature peripheral T cells (Juntilla, Wofford 
et al. 2007; Mao, Tili et al. 2007).   
One potential explanation for the decreased survival of Akt1/2 deficient T 
cells is an inability to properly regulate the pro-survival molecules Bcl-xL and A1, 
common targets regulated by Akt (Veis, Sentman et al. 1993; Mandal, Borowski 
et al. 2005).  Another possibility is that the decreased glucose uptake and cell 
size observed in Akt1/2 deficient thymocytes results in sub-optimal metabolism.  
Given that cells at the β-selection checkpoint are about to undergo intense 
proliferation that may require optimal energy levels for cell cycle progression and 
maturation of the cell. The role of Akt1/2 in an analogous stage of early B cell 
development, the pre-BCR mediated proliferative burst, is unknown. 
Another receptor critical to T-cell development and capable of activating 
Akt is Notch.  Ciofani et al showed enhanced Akt activation and glucose 
metabolism in thymocytes cultured with Notch ligands and a constitutively active 
form of Akt could overcome the requirement for Notch during T cell development 
(Ciofani and Zuniga-Pflucker 2005).  These data suggest that pre-TCR and 
Notch signaling converge on the PI-3K/Akt pathway.  In peripheral B cell 
development, signaling from the Notch2 receptor is required for the generation of 
MZ B cells (Saito, Chiba et al. 2003).  Furthermore, studies have recently 
demonstrated that Notch signaling can synergize with the BCR to enhance Akt 
activation (Thomas, Calamito et al. 2007).  A potential interplay between the 
BCR, Notch and Akt remains unexplored in MZ B cell development. 
 22 
1.6  The gamma-secretase substrate Notch 
 MZ B-cell development possesses a unique requirement for Notch signals 
(Saito, Chiba et al. 2003). Notch is expressed in four isoforms (Notch 1-4) with 
Notch2 preferentially expressed in mature B cells.  Notch signaling is initiated by 
binding to one of it’s 5 ligands, Jagged 1/2 or Delta-like 1/3/4, leading to 
shedding of the extracellular domain via the activity of ADAM (A Disintegrin and 
Metallopeptidase) metalloproteases.  Shedding enables the remaining 
transmembrane stalk to be opened up to intramembrane cleavage by the gamma 
secretase (γ-secretase) complex.  The cytoplasmic cleavage product, intracellular 
Notch (ICN), translocates to the nucleus and binds the transcription factor CSL 
(for human, CBF1; Drosophila, Suppressor of Hairless; C. elegans, Lag-1) and 
the co-activator mastermind-like protein (MAML). This complex initiates 
transcription of Notch target genes, including members of the hairy and enhancer 
of split (HES) family (Maillard, Fang et al. 2005).  Conditional deletion of Notch2, 
CSL, Notch ligand delta-like1 (DL1), or expression of a dominate negative MAML 
(DNMAML), which blocks canonical Notch signaling through all four Notch 
receptors, causes the specific loss of MZ B-cells (Tanigaki, Han et al. 2002; 
Saito, Chiba et al. 2003; Hozumi, Negishi et al. 2004; Maillard, Weng et al. 2004).  
Notch signaling may down modulate PTEN expression, and thus enhance PI-3K 
activity, via HES1, in T-lymphomas (Palomero, Sulis et al. 2007; Calzavara, 
Chiaramonte et al. 2008).   Furthermore, in-vitro studies from our lab have shown 
that FOL-B cells stimulated through the BCR and co-cultured with OP9 stromal 
cells expressing-DL1 (OP9-DL1) have increased levels of activated Akt 
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compared to FO-B cells cultures with control OP9-GFP cells (Thomas, Calamito 
et al. 2007).  These observations coupled with the requirement for PI-3K activity 
in MZ B cell generation raise the prospect of an important role for Akt 
downstream of Notch in B cell biology.  Furthermore, splenic B cells express 
mRNA for DL1 (Hozumi, Negishi et al. 2004).  The role B cell intrinsic Notch 
ligands play in B cell activation remains undefined. 
 
1.7 The γ-secretase complex and Presenilin   
 Within the immune system γ-secretase is mainly associated with Notch 
signaling, as Notch activation requires the γ-secretase-dependent cleavage of 
Notch receptors within the plasma membrane (Maillard, He et al. 2003).  The γ-
secretase complex is a membrane-embedded aspartyl protease composed of 
four different proteins: Presenilin (PS), Nicastrin, and Anterior Pharynx-Defective-
1 (Aph-1), and Presenilin Enhancer 2 (PEN2) (Parks and Curtis 2007).  The 
catalytic activity of γ-secretase is contained in the PS proteins, consisting of two 
separately encoded isoforms Presenilin 1 (PS1) and Presenilin 2 (PS2).  PS 
proteins undergo endopreoteolysis and the amino and carboxy terminal 
fragments function together as a heterodimer in the mature γ-secretase complex.  
Nicastrin is responsible for the recognition and binding of substrates and along 
with PEN2 and APH1 play a role in the stability of the complex (Li, Wolfe et al. 
2009).  The complex is thought to contain a protenaceous pore that is protected 
from the lipid bilayer and provides the hydrophobic environment required for 
catalytic activity.  Interestingly, the complex drives cleavage of a large number of 
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single-pass transmembrane proteins, over 80 to date, with rather promiscuous 
cleavage site specificities and is expressed at the plasma membrane in lipid 
rafts, endoplasmic reticulum (ER) and the golgi. (Parks and Curtis 2007; Li, 
Wolfe et al. 2009).  Furthermore, a large body of work has demonstrated that 
Presenilin proteins have both catalytic dependent and independent functions 
affecting cell adhesion, protein localization/trafficking, apoptosis, development 
and calcium regulation (Selkoe and Wolfe 2007).   Mutations in PS1 and PS2 
have been linked to familial Alzheimer’s disease (FAD) (Hass, Sato et al. 2009). 
Recent work has demonstrated that deletion of both PS1 and PS2 in developing 
thymocytes compromised TCR-mediated positive selection (Laky and Fowlkes 
2007), suggesting a role for Presenilin and by extension γ-secretase activity in 
antigen receptor activation and lymphocyte selection during development.   A 
recent paper by Yagi et al further demonstrated the importance of Presenilin 
proteins in B cell development, as PS1 PS2 double deficient cells failed to 
generate the MZ B lineage, presumably due to failed Notch2 activation (Yagi, 
Giallourakis et al. 2008).  These authors also showed that Syk activation 
downstream of the BCR was compromised in the absence of PS1 and PS2.  
Given that the catalytic subunit of the γ-secretase complex, Presenilin, can be 
isolated from various compartments of the cell, and that the complex can cleave 
numerous substrates, the potential exists for both Notch dependent and Notch 
independent functions for Presenilin and by extension γ-secretase in B cell 
development and activation that to date are ill defined. 
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Figure 3:  PI-3K mediated signaling cascades.  PI-3K is recruited to the plasma 
membrane by the activity of the BCR, CD19, Notch and BR3.  PI-3K mediated generation of 
PIP3 is modulated by the activity of PTEN. PIP3 concentrations influence the activation of Akt 
dependent and Akt-independent pathways.  Akt dependent effects include increased 
metabolism, enhanced survival, positive regulation of cell cycle progression, and down-
modulation of Foxo family transcription factors allowing decreased expression of RAG.  Akt 
independent pathways include activation of Btk and PLCγ2 enabling generation of IP3 
leading to mobilization of endoplasmic reticulum Ca2+ stores and transcription factor 
activation.   
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1.8 Summary Chapter 1 
 The biochemical pathways critical to B cell development remain poorly 
defined. Central to B lineage generation and cell fate decisions is the BCR.  The 
fact that active PI-3K signaling can substitute for the BCR in the survival of 
mature B cells demonstrates it’s essential role in B cell biology.  PI-3K’s ability to 
activate numerous downstream effectors, including Akt, raises questions about 
the Akt dependent functions of PI-3K.  I aimed to explore the role of Akt1 and 
Akt2 in B cell development and activation. In Chapter 3 I describe an essential 
and non-redundant function for signals derived from Akt1 and Akt2 in the 
development of MZ and B1 B cells.  I also show that Akt signaling is critical to 
BCR repertoire formation, as measured by λ-light chain frequencies, and the 
competitive fitness of peripheral B cell populations.  Furthermore, Akt is required 
for normal proliferation to BCR cross-linking.  I demonstrate, through use of a 
Bcl-xL expressing retrovirus, that poor survival is not the sole reason for the block 
in MZ B cell development (Calamito, Juntilla et al. 2009).  Finally, constitutively 
active Akt signaling, while sufficient to drive developing B cells to the MZ fate, is 
insufficient to rescue a Notch loss of function approach.  
 Data published from our lab demonstrated a synergy between γ-secretase 
substrate Notch and the BCR, enabling increased Akt signaling and proliferation 
(Thomas, Calamito et al. 2007).  In Chapter 4 I further explore this connection as 
it relates to BCR activation and find that while Notch enhances BCR mediated 
proliferation it is not required.  Strikingly, in experiments initially performed with γ-
secretase inhibitors (GSI) and then with a genetic loss of function approach I 
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uncover an unanticipated requirement for the γ-secretase complex (GS) in 
optimal BCR activation independent of the Notch pathway.  In addition, I show 
that conditional deletion of the γ-secretase complex subunit Presenilin from the B 
cell lineage results in a profound block in the development of B1 and MZ B cells.  
Finally, I observe altered BCR repertoire formation and abnormal calcium 
mobilization downstream of the BCR in B cells deficient in Presenilin proteins 
(Calamito et al. submitted 2010).   
 Years of intense study by numerous labs have uncovered a great deal of 
information about the factors critical to B cell development and thus the humoral 
immune response. My work, contributes to our understanding of these 
requirements, defining for the first time the importance of Akt in B cell 
development and uncovering an unexpected role for the Presenilin family of 
proteins in B cell biology independent of the Notch pathway.    
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CHAPTER 2: Materials and Methods 
 
2.1 Animals 
C57BL/6 and CD19-Cre mice were purchased from Jackson Laboratories (Bar 
Harbor, ME). B6.Ly5SJL females were obtained from the National Cancer Institute 
(Frederick, MD). Mice deficient in Akt1 or Akt2 were provided by Dr. Morris 
Birnbaum (University of Pennsylvania), Rosa26-DNMAML and floxed Presenilin 
1 Presenilin 2 null mice were provided by Dr. Warren Pear (University of 
Pennsylvania) and Dr. BJ Fowlkes (NIH), respectively.  Myristoylated-Akt mice 
provided by Dr. Hooman Noorchashm (University of Pennsylvania).  All animal 
procedures were approved by University of Pennsylvania Institutional Animal 
Care and Use Committee.  
 
2.2 Chimera Construction 
Fetal liver cells from B6.Ly5SJL, or B6-backcrossed (Ly5B6+) embryos lacking one 
or two alleles of Akt1 and/or Akt2 were harvested at day 14.5-16.5 postcoitum, 
and cultured overnight in αMEM with 20% FBS, 2.2g/liter sodium bicarbonate, 
2mM glutamine, penstrep, 10ng/mL IL-6, 20ng/mL IL-3 and 100µg/mL stem cell 
factor.  Host B6.Ly5SJL female mice were irradiated with two doses of 550 rads at 
least four hours apart. Six hours after the second irradiation 2.5 x 105 cells were 
injected intravenously.  For double chimeras B6.Ly5SJL progenitors were mixed 
50:50 with Akt deficient cells before injection into irradiated B6.Ly5SJL females. 
Hosts were maintained on water containing a Bactrim suspension (400 mg 
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sulfamethoxazole and 80 mg trimethoprim per 500 ml water) for two days prior 
to, and at least two weeks following irradiation.  Water was changed and a new 
dose of Bactrim added every two to three days. 
 
2.3 Flow Cytometry 
For flow cytometric analyses RBC-depleted cell suspensions from BM, spleen or 
peritoneal cavity were prepared and stained with optimal dilutions of directly 
conjugated antibodies in FACS buffer (1xPBS, 5% BSA, 1mM EDTA) before 
analysis a 14-color LSR II flow cytometer (BectonDickinson, San Jose, CA) 
equipped with four lasers for excitation of UV, violet, blue, and red-excited dyes. 
1-2 x 106 cells were stained with optimal dilutions of antibodies in a 96-well round 
bottom plates in a final volume of 50µL. Antibodies used included fluorescein 
(FL), phycoerythrin (PE), PE-Cy5.5, PE-Cy7, allophycocyanin (APC), APC-
Cy5.5, APC-Alexa750 or biotin (BI)-conjugated versions of monoclonal 
antibodies to the following cell surface antigens: Gr-1 (8C5), F4/80 (BM8) Ter-
119, CD3 (2C11), CD127/IL-7Ra (A7R34), CD135/Flt3 (A2F10), CD117/c-kit 
(2B8), Sca-1/Ly6 A/E (E13-161.7) B220 (RA3-6B2), CD43 (S7), CD23 (B3B4), 
IgM (331), κ (187.1), λ1-3 (R26-46), λ1-2 (JC5-1), CD21/35 (7G6), Ly5B6 (104), 
Ly5SJL (A20), CD11b (M1/70), C1qR/AA4 (AA4.1), CD5 (53-7.3) and CD19 (6D5). 
Polyclonal FL-conjugated Fab goat-anti-IgM antibodies (Jackson 
ImmunoResearch) were also employed. BI-conjugated antibodies were revealed 
with streptavidin (SA) coupled to PE-TexasRed (Caltag, Burlingame, CA). All 
directly conjugated antibodies were purchased from eBiosciences (San Diego, 
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CA) except for APC-Cy5.5 CD19 (Caltag), PE κ (BD Bioscience) Fitc λ1-3 (R26-
46) (BD Bioscience), PE λ1-2 (JC5-1) (Southern Biotech), and PE-Cy5.5 
CD21/35 which was purified and conjugated by standard methods in our 
laboratory. Non-viable cells were excluded from all analyses by staining with the 
UV-excited DNA dye DAPI. All flow cytometric data were analyzed by uploading 
files into FlowJo 8.8 (Tree Star, Inc., San Carlos, CA). Cell sorting was performed 
on a FACS Aria three lasers for excitation of violet, blue, and red-excited dyes. 
 
2.4 Magnetic activated cell sorting enrichment of splenocytes  
Follicular splenic B cells were isolated by first mechanical dissociation between 
two frosted glass slides.  The resulting mixture was then passed through 80µM 
filter (Fisher Scientific).  Red blood cell lysis with ACK (NH4Cl, KHCO3, Na2-
EDTA) for 5 minutes on ice and washed in FACS buffer (1xPBS, 5% BSA, 1mM 
EDTA).  Cells were spun down and the supernatant decanted.  Cells re-
suspendend in 2mL of FACS buffer per spleen and 5ul of anti-CD23 biotin (lab 
made) added for 15 minutes at 4°C.  Cells then washed in 13mL of FACS buffer, 
spun down and the supernatant decanted and re-suspended in 1mL per spleen 
of FACS buffer.  80µL/mL of streptavidin microbeads was added and enrichment 
of FOL B cells a positive selection using BI-CD23 antibodies and SA microbeads 
with (MACS) LS columns (Miltenyi Biotec Auburn, Ca) according to the 
manufacturer’s instructions resulting in purity greater than 95%.   
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2.5  In-vitro B cell cultures  
 To assess cell division, splenic B cells isolated as above, were labeled 
with 5µM CFSE (Invitrogen, Carlsbad, CA) for 2 minutes in PBS. Subsequently 2 
x104 CD23+ cells per well were cultured in a 96 Ill plate in RPMI 1640 with 10% 
FBS, 2mM L-glutamine, 0.1mM nonessential amino acids, 1xOPI, 55µM b-ME, 
and 10mM HEPES. Cells were stimulated with F(ab’)2 goat anti-mouse IgM 
(Jackson ImmunoResearch), LPS (Sigma), CpG (IDT). Cultures in which γ-
secretase inhibitors (GSI, compound E, Calbiochem) were used, GSI was at 
100nM.  For [3H]-thymidine experiments, 2x104 sorted B cells per well were 
cultured in triplicate per condition for 3 days before being pulsed with 1µCi 
(0.037MBq) before harvesting.  Cells were collected onto Filtermat (PerkinElmer 
Life Sciences) and analyzed on a MicroBeta Trulux scintillation counter 
(PerkinElmer Life science).  For mixing experiments, 2x104 total cells per Ill (3:1 
ratio PS1/2 DKO: WTSJL) were cultured for three days and harvested. For 
staining cells were first incubated on ice for 15min with FcR Block (2.4G2), and 
then stained with Ly5B6 (104) and Ly5SJL (A20) and CFSE dilution assessed on a 
FACS Canto. 
 
2.6 Quantitative real-time PCR 
Cells from at least three C57BL/6 mice were pooled and 1x105 cells from each 
respective population sorted on a FACS Aria. Tissue samples from liver and 
brain were not sorted but isolated in bulk.  Qiagen (Valencia, CA) RNeasy Mini 
Kits were used to isolate RNA as per instructions provided with the kit, and RNA 
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was reverse transcribed using first strand cDNA synthesis kit, protocol provided 
in kit (GE Healthcare). Quantitative RT-PCR (qRT-PCR) was performed using 
pre-validated Taqman primer/probes set for Akt1, Akt2, and Akt3 with 18s used 
as an endogenous control (Applied Biosystems, Fostre City, CA). Data were 
normalized to respective Akt isoform expression in follicular B cells. In addition, 
delta-CT values were calculated by subtracting the average Ct for the 18s 
primer/probe for each population from the respective Akt isoform. For Akt1-/- Akt2-
/- B cell populations were sorted as above and Akt3 transcript levels compared to 
the corresponding population from wild type mice. 
 
2.7 Retroviral supernatant 
293T cells were co-transfected with either MigR1-GFP, MigR1-Bcl-xL-GFP, or 
MigR1-DNMAML-GFP and helper plasmid as per protocols outlined in (Pear 
2001).  Fuguene (Roche) mediated transfection was performed with 8-12µg 
MigR1 constructs and 4-6µg helper plasmid.  Cell culture supernatants harvested 
24 and 48 hours post transfection and stored at -80°C. 
2.8 Retroviral transduction  
Bcl-xL 
MigR1-GFP or MigR Bcl-xL GFP constructs were transduced by retro-virus into 
AKT DKO day 15 fetal liver cells.  Fetal liver cells were harvested as above and 
placed into aMEM media supplemented with 10% FCS, 2mM glutamine, 1% 
penstrep, 10ng/mL IL-6, 20ng/ml IL-3, and 100µg/mL stem cell factor.  1 day after 
harvest cells were subject to spinfection with respective virus + 10µg/mL 
 33 
polybrene for 90 min (2500PRM) at 25°C, then placed at 37°C overnight.  
Spinfection was repeated the next day, and cells rested for an additional 6 hrs.   
Cells were washed 3x in 1xPBS in a total volume of 50mL each wash, and 
2.5x105 cells injected into irradiated B6SJL hosts as above. 
DNMAML  
MigR1-GFP or MigR-DNMAML GFP constructs were transduced into Class II 
controlled Myr-Akt bone marrow similar to above, B220, CD3, Gr-1 depleted 
adult bone marrow used in place of fetal liver. 
 
2.9 Tat-Cre Incubation 
For induction of Rosa26 +/DNMAML-GFP cells, splenic CD23+ B cells were isolated as 
above and washed in HyClone Serum Free media three times and re-suspended 
at a final concentration of 5x106/mL with 50µg/mL Tat-Cre for 45min at 37°C.  
Pulse was stopped by addition 10x volume of Hyclone media with 10% FBS.  
Cells washed twice and rested for 16hrs before sorting live B cells (B220+ Dapi-) 
on FACS Aria.   
 
2.10 Calcium Mobilization 
10x106 /mL splenic B cells isolated by positive selection as described above in 
RPMI 1640 with 10% FBS and loaded with Indo-1AM (invitrogen) 7µg/mL for 
45min at 37°C, mixing every 15min.  Cells were washed twice in media and run 
on an LSR II flow cytometer (Beckton Dickinson).  Indo-1 fluorescence was 
analyzed using a 450-DC-LP dichroic beam splitter and emission filters at 530/30 
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and 405/20 for free and bound probes respectively.  Each sample was run for 
60s to collect baseline, then 15µg/mL F(ab’)2 goat anti-mouse IgM (Jackson 
ImmunoResearch) was added and collected for an additional 150s at which time 
the tube was removed and 1µg/mL ionomycin (Sigma) was added and the 
sample collected for an additional 60s.  Thapsigargin 1µM (Fisher Scientific) 
treated samples were collected similar to above.  Measurement of anti-IgM or 
thapsigargin mediated intracellular Ca2+ store release was performed by adding 
12.5 mM EGTA (Fisher Scientific).  All samples collected in linear mode on 
FACSDiva (Beckton Dickinson) software and analyzed in FlowJo 8.8 (Tree Star, 
Inc., San Carlos, CA ) using kinetic analysis. 
 
2.11 Statistical Analysis 
All cell percentages and cell numbers were evaluated with unpaired two-tailed t-
test using Excel software.  Absolute cell numbers were calculated by multiplying 
the frequency of cells within each B cell subset by the total cells harvested from 
each respective organ.  
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CHAPTER 3 Akt signaling promotes peripheral B cell development and 
competitive fitness 
3.1 Introduction:  Importance of Akt signaling in B cell development 
 The serine/threonine kinase Akt consists of three individually encoded 
family members termed Akt1, Akt2, or Akt3 (Easton, Cho et al. 2005; Plas and 
Thompson 2005).  All three isoforms are similar in structure but vary in 
expression pattern across different tissues (Manning and Cantley 2007).  
Regardless of cell type or tissue context, Akt signaling is an important mediator 
of survival, metabolism, and cell cycle progression (Yang, Tschopp et al. 2004).  
Akt lies downstream of phosphatylinositol-3 kinase (PI-3K), a critical target of  
antigen receptor signaling in both B cells and T cells; in addition to Akt, PI-3K  
also activates other downstream effectors pathways including Tec family kinases 
and PLCγ (Okkenhaug and Vanhaesebroeck 2003; Fruman 2004). 
 In B cells, PI-3K is recruited to the plasma membrane upon cross-linking 
of surface BCR molecules, and recruitment of PI-3K is enhanced by the B cell 
specific co-receptor CD19 (Del Nagro, Otero et al. 2005).  Antigen receptor 
mediated stimulation of PI-3K leads to a transient activation of Akt in B cells, co-
ligation of the BCR and CD19 results in the sustained activation of Akt (Otero, 
Omori et al. 2001).  In B cells, both PI-3K and CD19 are dispensable for early B 
cell development in the bone marrow but are required for the normal generation 
of peripheral B cells, such as the B1 and MZ B cell compartments (Otero, 
Anzelon et al. 2003; Otero and Rickert 2003). The role of Akt, downstream of PI-
3K in B cell development remains unclear.  
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 In this chapter I present results that demonstrate a critical and non-
redundant role for Akt1 and Akt2 in the development of the peripheral B cell pool.  
To elucidate these findings I generated chimeras established with Akt1 and Akt2 
deficient fetal liver and found that B1a and MZ B cell development was 
profoundly blocked in Akt1/2 deficient chimeras.  In contrast to peripheral B cell 
development, immature B cells in the bone marrow were only mildly perturbed. In 
addition, Akt1/2 deficient progenitors are poor competitors starting at the late 
transitional stage of peripheral B cell development.  The BCR repertoire is altered 
and proliferative responses to BCR cross-linking are dampened in Akt1/2 
deficient FOL B cells. Examination of Akt mRNA expression across multiple 
subsets of B cells by qRT-PCR revealed that Akt3 expression is reduced in MZ 
and B1 subsets relative to FOL B cells.  Interestingly, though Akt3 expression 
decreases in the B cell subsets most affected by the loss of Akt1 and Akt2 I 
observed that the overall level of Akt3 mRNA was significantly increased 
compared to Akt2 (Calamito, Juntilla et al. 2009). 
 Given the role of Akt in cell survival, I examined the effect of ectopic 
expression of the pro-survival gene Bcl-xL , through retroviral transduction of 
Akt1/2 deficient progenitors and found it insufficient to rescue MZ B cell 
development.  Furthermore, the Akt pathway has previously been implicated as 
downstream of the Notch family of receptors in thymocyte development (Ciofani 
and Zuniga-Pflucker 2005) and enhanced Akt activation has been reported in B 
cells exposed to cross-linking anti-IgM antibody in the presence of Notch ligands 
(Thomas, Calamito et al. 2007).  In addition, Notch signaling is required for the 
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generation of MZ B cells, but dispensable for other B cell lineages (Tanigaki, Han 
et al. 2002; Saito, Chiba et al. 2003; Hozumi, Negishi et al. 2004; Maillard, Weng 
et al. 2004; Wu, Maillard et al. 2007).  To examine the role of Akt downstream of 
Notch I introduced a dominant negative mastermind (DNMAML), capable of 
blocking all Notch receptor signaling, into bone marrow progenitors from mice 
harboring a class II promoter driven transgene harboring a constitutively activate 
form of Akt (Kouskoff, Fehling et al. 1993; Tuttle, Gill et al. 2001; Maillard, Weng 
et al. 2004)  This system demonstrated that while an active Akt drives B cells 
toward the MZ B cell fate, the presence of this transgene is not sufficient to 
rescue a Notch loss of function.   
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3.2 Chapter 3 Results 
3.2.1  Early B cell development without Akt1 and Akt2.   
 Developing B cells undergo intense proliferation at the pro to pre B 
transition (Nemazee 2006), given Akt’s documented role in cell cycle progression 
and survival I sought to examine the role of Akt in early B cell development.  
Bone marrow B cell populations were not affected in the absence of a single 
isoform of Akt1 or Akt2 (not shown).  To assess the role of Akt1 and Akt2 in B 
cell development, I transferred fetal liver cells carrying null mutations for Akt1 
and/or Akt2 into lethally irradiated Ly5 congenic hosts, and allowed 12-14 weeks 
for full reconstitution (Fig 4). Use of the fetal liver chimeras was required due to 
the neonatal lethal phenotype of Akt1-/- Akt2-/- (Akt1/2 DKO) mice (Peng, Xu et al. 
2003; Juntilla, Wofford et al. 2007). Although combined expression of Akt1 and 
Akt2 is required for thymopoiesis beyond the pre-TCR checkpoint, Akt1/2 DKO 
progenitors readily generated pre-BCR-dependent pre-B cells in the bone 
marrow as well as downstream immature B cells (Fig. 5A). Indeed, if anything 
frequencies of Akt1/2 DKO donor-derived pro- (B220low CD43+ AA4+ CD19+), pre- 
(B220low CD43- AA4+ CD19+ sIgM-) and immature (B220low CD43- AA4+ CD19+ 
sIgM+) BM B cells were elevated. Numbers of pro-, pre-, and immature B cells 
were increased ~3, ~4, and ~2 fold, respectively, compared to chimeras 
reconstituted with Akt1+/+ Akt2+/- progenitors (Fig. 5B).  In contrast, frequencies 
and cell numbers of mature recirculating BM B cells derived from Akt1/2 DKO 
progenitors were decreased significantly compared to Akt1+/+ Akt2+/- progenitor 
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controls (Fig. 5A/B). I conclude that the combined expression of Akt1 and Akt2 
are not required to generate pre-B and immature B cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Experimental Set-up of Akt1/2 DKO fetal liver chimera 
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Figure 5. Akt-deficient progenitors generate marrow B-lineage precursors. (A) 
Representative flow cytometric analysis of BM cells from chimeras established with 
Akt1+/+ Akt2+/- (top) or Akt1-/- Akt2-/- (bottom) progenitors 12-14 weeks previously. 
The left-most plots are gated on viable donor-derived (DAPI- Ly5B6+) cells. Numbers 
in plots indicate the frequency of events in the indicated gate as a function of the 
indicated parent population. Pro-B, CD43+ B220+ CD19+ AA4+; pre-B, CD43low 
B220+ IgM- AA4+; immature B, CD43- B220+ IgM+ AA4+; mature B, CD43- B220+ 
IgM+ AA4-. (B) Absolute cell numbers for respective BM populations were calculated 
using the gates shown in (A) (see methods). Error bars indicate the SEM for each 
group, n=5. Data representative of two separate experiments. **= p<.01 
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3.2.2  Akt1-2 deficient precursors fail to generate MZ B cells.  
 The decreased numbers of Akt1/2 DKO mature B cells in the BM raised 
the possibility of a role for Akt in peripheral B cell development.  To examine this 
issue I assessed splenic B cell compartments in Akt1/2 DKO reconstituted 
animals. In chimeras established with Akt1/2 DKO progenitors, the donor-derived 
follicular B cell pool was decreased only 2-fold compared to chimeras generated 
with Akt1+/+ Akt2+/- progenitors. Furthermore frequencies of AA4+ transitional B 
cell subpopulations, defined by differential expression levels for CD23 and IgM 
(termed T1, T2, and T3), were largely unaffected. In contrast, the development of 
MZ B cells was highly dependent on signaling derived from Akt1 and Akt2, as I 
was unable to detect donor-derived CD21high IgMhigh CD23low MZ B cells in 
chimeras established with Akt1/2 DKO progenitors (Fig. 6). Numbers of splenic 
MZ B cell precursors (MZPs), considered immediate precursors for MZ B cells, 
were decreased 3-fold compared to control chimeras (Figure 6B). Analyses of 
mice deficient in either Akt1 or Akt2 exhibited a normal MZ B cell population (not 
shown), suggesting that Akt1 and Akt2 perform overlapping functions required for 
MZ B cell development. Altogether, these data show that MZ B cell development 
is critically dependent on the combined expression of Akt1 and Akt2.   
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Figure 6.  MZ B cell development is highly dependent on Akt1/2. (A) Representative analysis 
of splenocytes from chimeras established with Akt1+/+ Akt2+/- (top) or Akt1-/- Akt2-/- (bottom) 
progenitors 12-14 weeks previously. Viable donor-derived cells were gated as in Figure 1. 
Numbers in plots show the frequency of events as a function of the indicated parent gate. (B) 
Absolute cell numbers for respective splenic B cell subsets Ire calculated using the gates shown in 
(A) (see methods). Error bars indicate the SEM for each group, n=5. Data representative of two 
separate experiments. *=p,.05 
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3.2.3  Defective B1 B cell development in Akt1/2-deficient chimeras.  
 Mice lacking CD19 or the catalytic subunit of PI-3K, p110δ, fail to generate 
MZ and B1 B cells (Clayton, Bardi et al. 2002; Jou, Carpino et al. 2002; 
Okkenhaug, Bilancio et al. 2002), given that Akt is a major down stream target of 
the PI-3K pathways I hypothesized that B1 B cell development might be 
compromised in the absence of optimal Akt expression.  Therefore I analyzed 
frequencies of donor-derived B1 B cells in the peritoneal cavity. As shown (Fig. 
7), whereas animals reconstituted with Akt1+/+ Akt2+/- progenitors generated 
abundant numbers of CD19+ CD43+ B1 peritoneal cavity B cells, the donor-
derived B1 B cell pool was detectable but significantly diminished in chimeras 
established with Akt1/2 DKO progenitors. Further, frequencies of CD5+ B1a cells 
were severely decreased, whereas CD5- CD43+ B1b cells were reduced only 2-
fold. I conclude that the generation of B1a B cells is also highly dependent on the 
Akt pathway and this interpretation is in agreement with previous observations 
demonstrating the importance of the PI-3K signaling pathway in the generation of 
both MZ and B1 B cells.   
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Figure 7. Requirement for Akt1/2 for B1 B cell development. (A) Representative analysis 
of peritoneal cavity lymphocytes from chimeras established with Akt1+/+ Akt2+/- (top) or Akt1-/- 
Akt2-/- (bottom) progenitors 12-14 weeks previously. The left-most plots are gated on viable 
donor-derived B cells (DAPI- Ly5B6+ CD19+). Numbers in plots show the frequency of events 
as a function of the indicated parent gate. (B) Average frequencies for the indicated subsets 
Ire calculated using the gates shown in (A). B2, CD19+ B220+ CD43-; B1, CD19+ B220+ 
CD43+; B1a, CD19+ B220+ CD43+ CD5+; B1b, CD19+ B220+ CD43+ CD5-. Error bars indicate 
the SEM for each group, n=5. Data representative of two separate experiments.  **=p<.01, 
***=p<.005 
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3.2.4  Diminished proliferation to BCR aggregation without Akt1/2.  
 B1a and MZ B cell development both require optimal selection via the 
BCR. In addition, past studies suggest that BCR aggregation leads to activation 
of Akt (Craxton, Jiang et al. 1999). I therefore assessed BCR-mediated activation 
and proliferation in Akt1/2 deficient B cells. I isolated CFSE-labeled CD23+ 
splenic B cells from Akt1/2 DKO or control reconstituted chimeras and stimulated 
them with increasing concentrations of anti-IgM antibodies. After 3 days, Akt1/2 
deficient B cells exhibited decreases in the number of cell divisions induced by 
IgM aggregation and markedly decreased survival as assessed by uptake of the 
DNA dye 7-AAD (Fig. 8A), resulting in significant decreases in numbers of viable 
B cells (Fig. 8B). Furthermore, while the number of cell divisions occurring in 
response to the TLR-4 agonist lipopolysaccharide (LPS) was largely unchanged 
between Akt1/2 DKO and Akt1+/+ Akt2+/- B cells, overall cell recoveries for Akt1/2 
DKO follicular B cells were significantly reduced, likely due to increased cell 
death (Fig. 8). These data suggest that, optimal BCR-mediated B cell 
proliferation requires Akt1 and Akt2.  
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Figure 8. Akt1/2-deficient B cells exhibit a defective BCR-mediated proliferative 
response. (A) CFSE-labeled CD23+ follicular B cells were left unstimulated (top plots) or 
stimulated with 50mg/ml anti-IgM antibodies (middle) or 1ug/mL of LPS (bottom) for 3 days, 
stained with the viability dye 7AAD, and analyzed by flow cytometry. The right-most overlay 
histograms were gated on viable (7AAD-) cells using the gates indicated in the corresponding 
plots. Black line, Akt1-/- Akt2-/-; gray filled curves, Akt1+/+ Akt2+/-. (B) Mean numbers of viable 
Akt1-/- Akt2-/- or Akt1+/+ Akt2+/- B cells recovered from triplicate cultures stimulated with the 
indicated concentrations of anti-IgM antibodies or LPS were calculated by flow cytometry 
using the 7AAD- gates shown in (A). Error bars indicate SEMs from 4 animals per group. 
Representative of two separate experiments. ***=p<.005 
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3.2.5  The Akt pathway promotes competitive fitness of mature B cells in 
vivo.  
 Past work illustrates that mature B cells lacking CD19 or the tec tyrosine 
kinase Btk are unable to compete against wild-type (WT) B cells in vivo (Sprent 
and Bruce 1984; Otero, Anzelon et al. 2003; Lindsley, Thomas et al. 2007).  This 
feature correlates with the inability of mature B cells from these mutants to 
undergo cell division upon BCR aggregation in vitro. Given the suboptimal 
survival of Akt1/2 DKO B cells in response to BCR cross-linking, I reasoned that 
Akt1/2 DKO B cells might also survive poorly when forced to compete against 
WT B cells. To test this possibility, I generated double chimeras in which equal 
numbers of C57BL/6 (Ly5B6) backcrossed Akt1/2 DKO or control Akt1+/+ Akt2+/- 
fetal liver progenitors were mixed with wild type progenitors from congenic 
B6.Ly5SJL mice before transplantation into irradiated B6.Ly5SJL adults. Four 
months later recipients Were assessed for the representation of Akt1+/+ Akt2+/- or 
Akt1/2 DKO-derived (both Ly5B6+) versus B6.Ly5SJL-derived (Ly5SJL+) B-lineage 
cells including BM pro- and pre-B cells, immature (AA4+ IgM+) B cells in the BM 
and spleen, and mature splenic follicular, MZP, and MZ B cells. To control for 
engraftment of progenitors from each donor, I also assessed the relative 
contribution of C57BL/6 versus B6.Ly5SJL progenitors to LSK (Lineage- c-Kit+ 
Sca1+) BM progenitor pool, which contains hematopoietic stem cells and early 
multipotent progenitors.  
In the BM, Akt1/2 deficient cells were highly competitive with WT cells 
within both the LSK pool and within all B-lineage precursor populations including 
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immature IgM+ B cells, as the degree of chimerism for each of these populations 
derived from Akt1/2 DKO progenitors paralleled that observed for Akt1+/+ Akt2+/- 
progenitors (Fig. 9B). In sharp contrast, all mature B cell populations including 
follicular and MZP B cells in the spleen and mature BM B cells were dramatically 
under represented in Akt1/2 DKO + WT compared to Akt1+/+ Akt2+/- + WT double 
chimeras (Fig. 9A and 9B). In addition, whereas Akt1/2 DKO and Akt1+/+ Akt2+/- 
cells were equally competitive within the least mature (T1) splenic transitional 
subset, I noted a partial loss of Akt1/2 DKO B cells within the more mature T2 
transitional subset. Furthermore, in additional double chimeras, Akt1-/- or Akt2-/- 
mature B cells displayed a substantial albeit incomplete inability to compete 
against WT cells (not shown).  Altogether these data suggest that the Akt 
pathway initiates cellular processes required for competitive survival as immature 
B cells transit from the T2 population into mature B cell pools.  
Blys and BR3 are major determinants of peripheral B cell numbers and 
recent publications demonstrate that Akt is downstream of BR3 (Patke, 
Mecklenbrauker et al. 2006; Otipoby, Sasaki et al. 2008; Woodland, Fox et al. 
2008).  This raised the possibility that BR3 signaling is defective in the absence 
of Akt1 and Akt2 thus providing a mechanistic explanation for the inability of 
Akt1/2 deficient cells to compete with WT cells.  To address this question, I 
isolated FOL splenic B cells from control or Akt1/2 DKO chimeras and cultured 
them in the presence of absence of Blys for 72 hrs assaying survival and 
metabolic fitness.  I found that survival as examined by exclusion of the viability 
dye 7-AAD, was enhanced after culture with Blys (Fig 10A).  Furthermore, Akt1/2 
 49 
deficient cells increased their cell size after culture with Blys, suggesting 
enhanced metabolic activity (Fig 10B).  Therefore Akt1/2 deficient FOL B cells 
are responsive to Blys in terms of survival and metabolism suggesting that BR3-
Akt1/2 signaling does not regulate FOL B cell survival in-vivo.  It is possible that 
the concentration of Blys utilized in these experiments (100ng/mL) is in such 
excess as to mask any defect downstream of BR3.  Alternatively, the absence of 
Akt1/2 downstream of BCR signaling could lead to poor generation of the Blys-
BR3 substrate p100 compromising the ability of Akt1/2 deficient B cells to 
respond to Blys. 
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Figure 9. Akt1/2-deficient B cells compete poorly with wild-type B cells. (A) Double 
chimeras were analyzed at 16 weeks post transplantation. (A) Representation of the indicated B 
cell subset derived from WT (Ly5SJL+) or Akt1+/+ Akt2+/- (top) or Akt1-/- Akt2-/- (bottom) 
progenitors. Each subset was gated as shown in Figure 2. (B) The average ratio of cells in the 
indicated subpopulation derived from Ly5B6+ and Ly5SJL+ progenitors in double chimeras 
established with Akt1+/+ Akt2+/- (gray columns) or Akt1-/- Akt2-/- (white columns) progenitors was 
calculated using gates shown in Figures 1 and 2 with 4 or 5 animals per group. Diamond and “X” 
symbols indicate individual mice. LSK, Lineage- c-Kit+ Sca-1+.  Representative of two separate 
experiments.   
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Figure 10:  Survival mediated by Blys is Akt1 Akt2 independent.  (A)  
Survival of CD23+ splenocytes from control (Grey) or Akt1/2 DKO (black).  
Viability assayed by exclusion of 7-AAD after 72hrs in-vitro culture.  (B) 
Cells assayed as above,  cell size of live (7-AAD-) cells. 
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3.2.6  Altered BCR repertoire in Akt1/2 deficient B cells 
 B cells deficient in CD19 or the downstream PI3K have altered λ+ light 
chain repertoires (Diamant, Keren et al. 2005; Llorian, Stamataki et al. 2007), 
given that our studies to this stage had demonstrated overlapping phenotypes 
betIen CD19, PI-3K and Akt I sought to determine if Akt1/2 deficient B cells 
demonstrated a similar BCR repertoire phenotype. Consistent with the notion of 
Akt being a major downstream target of PI3K, splenic FOL B cells (CD19+ AA4- 
IgMint CD21/35Int) from Akt1/2 deficient chimeras revealed a dramatic increase in 
the percentage of λ+ B cells (Fig. 11A and Table 3). The increase in λ+ B cells 
was also detected in both the T1 (CD19+ AA4+ CD23-)  and T2  (CD19+ AA4+ 
CD23+) splenic transitional B cell populations.  Furthermore, immature B cells in 
the bone marrow (B220+ CD43- AA4+ IgM+) also displayed increased frequencies 
of λ+ cells, suggesting that Akt1 and Akt2 are required at these early stages of B 
cell development to generate and shape the BCR repertoire.   
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Figure 11: Altered BCR repertoire in Akt ½ deficient B cells Representative analysis of 
bone marrow or splenocytes from chimeras established with Akt1+/+ Akt2+/- (top) or Akt1-/- 
Akt2-/- (bottom) progenitors 12-14 weeks previously. Viable donor-derived cells Ire gated as 
in Figure 4 and 5. Numbers in plots show the frequency of events as a function of the 
indicated parent gate.  Number of animals equals two (Akt1+/+ Akt2+/- ) or four  
(Akt1-/- Akt2 -/-). 
Table 3 Frequency of λ+ B cells in Akt1/2 deficient B cells 
Tissue Akt1 +/+  Akt2 +/- Akt1-/-  Akt2-/- 
Bone Marrow % λ  Positive 
Immature B 8.28 (.91) 13.5 (1.2) 
   
Spleen   
T1 8.0  (1.2) 12.2   (1.1) 
T2 6.3  (2.4) 12.6 (2.1) 
FO 4.6  (.59) 8.4   (.41) 
 
B cell subsets were defined as illustrated in figure 4 and figure 5  
Mean percent of viable gated populations of two (Akt1+/+ Akt2+/- ) or four (Akt1-/- 
Akt2 -/-).  Numbers in parentheses represent SEM. 
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3.2.7  Akt isoform expression across B cell subsets.  
 Since pre-B cell frequencies were increased and MZ, MZP, and B1 B cell 
frequencies decreased upon deletion of Akt1 and Akt2, I next sought to better 
define the expression of each Akt isoform throughout the B cell lineage. My initial 
analyses sought to address expression of each isoform in each immature and 
mature B cell subpopulation. As shown in Fig 12A, Akt1 and Akt3 transcripts 
were present at 3-6 fold higher levels for wild type pro- and immature B cells in 
the BM relative to follicular B cells in the spleen.  Though Akt3 transcripts were 
expressed at higher levels in immature relative to follicular B cells, the expression 
of Akt3 was still lower than brain, a tissue shown previously to express high 
levels of Akt3 (Easton, Cho et al. 2005).  Interestingly, Akt1 and Akt3 expression 
appeared to be down regulated both as pro-B cells give rise to pre-B cells, up-
regulated in immature B cells, and again down regulated as immature B cells 
give rise to mature B cells. In addition, relative to follicular B cells, transcript 
abundance for Akt1 and Akt3 was decreased further in MZ B cells and their 
immediate precursors (MZPs) in the spleen, and in both peritoneal cavity B1 
subpopulations. These observations contrast with the expression pattern for 
Akt2, which did not vary substantially among any of the B-lineage subsets 
examined (Fig. 12A) and was expressed at lower overall levels compared to 
Akt1 and Akt3.  
 Given that past studies have shown that Akt3 is expressed in 
unfractionated splenic B cells (Juntilla, Wofford et al. 2007), and pre-B cell 
development in wild type and Akt1/2 DKO precursors may be highly dependent 
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on Akt3, I sought to further quantify overall expression of each Akt isoform in 
each B-lineage population relative to 18s RNA. To this end, for each B-lineage 
population I divided the mean signal (Ct) for each Akt isoform by the mean Ct for 
18s RNA, thus yielding a delta-Ct for each Akt isoform within each population. As 
shown in Figure 12B, whereas Akt1 and Akt3 are expressed at similar levels 
among BM and peripheral B cell subsets, Akt2 is expressed at substantially lower 
levels (resulting in a significantly higher delta-Ct) in every population. In contrast, 
samples from mouse liver, a source of abundant Akt2 transcripts (Altomare, 
Lyons et al. 1998) demonstrated significantly lower delta-Ct values.  
 Finally, to address whether Akt3 expression increases in B-lineage cells 
such as pre-B cells lacking Akt1 and Akt2, I compared Akt3 transcript abundance 
in wild type and Akt1/2 DKO B-lineage cells. As shown in Figure 12C, Akt3 
expression was only modestly increased (1.6-fold) in Akt1/2 DKO pre-B cells 
compared to their wild type counterparts. Interestingly, whereas Akt3 transcript 
expression was unchanged in most other B-lineage cells, Akt3 transcripts were 
increased 3-fold in Akt1/2 DKO MZPs compared to wild type MZPs (Fig. 12C). 
Thus, while the absence of Akt1 and Akt2 in MZPs appears to result in increased 
mRNA levels for Akt3, this increase is insufficient to rescue MZ B cell 
development. Altogether, these data show that while Akt3 mRNA is expressed at 
substantial levels in developing and mature B cells, Akt3 expression alone is 
unable to drive MZ and B1 B cell development and follicular B cell competitive 
fitness. 
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Figure 12.  Expression of Akt isoforms in B-lineage Cells. (A) Relative Akt isoform 
expression in sorted BM, splenic and peritoneal B cell populations measured by qRT-PCR. 
Data are expressed relative to wild type follicular B cells. Brain and liver cDNA serve as 
positive controls for Akt3 and Akt2 mRNA, respectively. Error bars indicate the relative 
quantity minimum and relative quantity maximum for each sample. (B) Delta Ct values for 
Akt1, Akt2, and Akt3 relative to endogenous control 18s, within each of the indicated B cell 
populations as in (A). (C) Akt3 transcript abundance in sorted B cell populations from Akt1/2 
DKO chimeras relative to the corresponding wild-type population.  
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3.2.8  Ectopic Bcl-xL expression is insufficient to rescue marginal zone B 
cell development in the absence of Akt1 and Akt2.  
 Given that Akt plays a critical role in the regulation of pro-survival 
molecules down stream of PI-3K (Franke 2008) and transgenic expression of 
Bcl-xL was able to mediate rescue of splenic  B cell numbers in PI-3K deficient 
mice (Suzuki, Matsuda et al. 2003), I sought to examine the impact of retroviral 
mediated over-expression of Bcl-xL in Akt1/2 DKO progenitors.  Ectopic 
expression of Bcl-xL was able to rescue a substantial portion of mature 
recirculating B cells in the bone marrow demonstrating the potency of the Bcl-xL 
retrovirus.  I noted a decrease in the percentage of GFP+ pre and immature B 
cells to levels more representative of a wild-type bone marrow compartment (Fig 
13A,C).  While Bcl-xL did provide limited rescue to bone marrow B cell 
populations it was not sufficient to rescue MZ B cells in the spleen (Fig 13B,C).  
These data demonstrate that the pro-survival function of Bcl-xL is insufficient to 
rescue MZ B cell development the absence of Akt1 and Akt2.  Yet in recirculating 
B cell populations enhanced survival does provide benefit, highlighting the 
context dependent requirements for Akt in B cell development.  While it is 
possible that Akt still plays a critical role in the survival of MZ B cells these data 
suggest that Akt interacts with other biochemical pathways critical to the 
generation of MZ B cells.  
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Figure 13: Impact of enforced Bcl-xL expression fails on BM and peripheral B cell 
development from Akt1/2-deficient precursors. (A) Flow cytometric analysis of BM cells 
from chimeras established with Akt1-/- Akt2-/- progenitors transduced with retrovirus expressing 
MigR1-GFP control (Grey) or MigR1-Bcl-xL (Black) 8 weeks previously. The left-most plots are 
gated on viable donor-derived (DAPI- Ly5B6+) cells. Numbers in plots indicate the frequency of 
events in the indicated gate as a function of the indicated parent population. Pro-B, CD43+ 
B220+ CD19+ AA4+; pre-B, CD43low B220+ IgM- AA4+; immature B, CD43- B220+ IgM+ AA4+; 
mature B, CD43- B220+ IgM+ AA4-. (B) Flow cytometric analysis of spleen cells from chimeras 
in (A); MZ B cells Ire gated as in Figure 2. For (A) and (B) numbers in plots indicate the 
frequency of events as a function of the indicated parent population. (C) Percent of donor-
derived GFP+ cells within the pro, pre, immature, mature B cells pool of the BM and within the 
MZ precursor (MZP) and MZ B cell gates. Error Bars represent SEM for 2 mice in MigR1-GFP 
and 3 mice in MigR1-Bcl-xL.  
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3.2.9  The requirement for Notch in MZ B cell development is Akt 
independent. 
 A factor critical to MZ B cell development is the γ-secretase substrate 
Notch (Tanigaki, Han et al. 2002; Saito, Chiba et al. 2003; Hozumi, Negishi et al. 
2004; Maillard, Weng et al. 2004; Yagi, Giallourakis et al. 2008).  Recent 
experiments in thymocytes and follicular B cells support a role for the activation 
of Akt downstream of the Notch pathway (Ciofani and Zuniga-Pflucker 2005; 
Thomas, Calamito et al. 2007).  Given my observation that Akt1 and Akt2 are 
required for the generation of MZ B cells, I next sought to examine a potential 
Notch-Akt connection in MZ B cell development.  To test this hypothesis I utilized 
mice harboring a constitutively active N-terminal myristoylated Akt1 transgene 
(herein termed Mry-Akt) controlled by the MHC class II promoter (Kouskoff, 
Fehling et al. 1993; Tuttle, Gill et al. 2001).  This construct is expressed in a 
manner consistent with endogenous MHC class II genes and therefore will be 
expressed in mature B cells which maintain MHC class expression basally 
(Glimcher and Kara 1992).  Notch signaling was inhibited by retroviral expression 
of a dominant negative mastermind version of the Notch/CSL co-activator 
MAML1 (DNMAML) transduced into Myr-Akt positive or littermate control Myr-Akt 
negative bone marrow (Fig 14).  The DNMAML construct has previously been 
shown to block MZ B cells development and recapitulate Notch loss of function 
studies (Maillard, Weng et al. 2004). 
 Splenic B cells from chimeras established with control MigR1-GFP in Myr-
Akt positive progenitors demonstrated consistently increased frequencies of MZ 
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B cells demonstrating the activity of the Myr-Akt transgene and it’s positive effect 
on MZ B cell development (Fig 15A).  Despite the ability of Myr-Akt to positively 
impact MZ B cell development/ maintenance, expression of DNMAML in Myr-Akt 
positive B cells continued to block MZ B cell development. (Fig 15B) This data 
suggests, that while Notch can activate Akt in B cells, Akt activation alone is 
insufficient to replace Notch signaling.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14:  Experimental Set-up: Ectopic DNMAML expression in Myr-Akt background 
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Figure 15: Myristolayted Akt increases MZ B cell frequency but is insufficient to rescue 
Notch inhibition.  (A)  Flow cytometric analysis of splenic cells from chimeras  established with 
MigR1-GFP trandsduced bone marrow from Myristolyated-Akt (Myr-Akt)  negative littermate 
control (top) or Myr-Akt positive (bottom) twelve weeks post reconstitution.  The left most plots 
are gated on live (Dapi-) splenocytes.  Middle plots gated on CD19+ GFP-cells, right most plots 
gated on CD19+ GFP+.  Fraction I,II, and III gated as in figure 4.  Numbers represent frequencies 
of parent gate.  (B)  Flow cytometric analysis of splenic cells from chimeras established with 
dominant-negative mastermind (DNMAML) transduced bone marrow from Myr-Akt negative 
littermate control (top) or Myr-Akt positive (bottom) twelve weeks post reconstitution.  Gating as 
in (A).  Representative of two (MigR1-GFP control) or three (DNMAML) mice.   
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3.3 Chapter 3 Summary-Brief Discussion 
 I have characterized B cell development in the absence of Akt1 and Akt2.  
I find that signals derived from Akt1 and Akt2 are not required for the pro to pre B 
transition, indeed the total cell counts for each of these respective pools is 
increased relative to controls.  In the periphery, MZ and B1 cell development is 
dramatically impaired, and the competitive fitness of FOL B cells is compromised 
in the absence of Akt1 and Akt2 (Fig 16).  This phenotypic characterization is 
reminiscent of the B cell phenotypes observed in PI-3K and CD19 loss of 
function animals (Rickert, Rajewsky et al. 1995; Donahue, Hess et al. 2004; 
Okkenhaug, Ali et al. 2007) and supports the hypothesis that Akt is a critical 
target of the PI-3K pathway in peripheral B cell development.  The increased 
frequency and number of pro, pre and immature B cells in the bone marrow of 
Akt1/2 deficient chimeras could suggest a bottleneck in development by which 
the remaining Akt3 is unable to efficiently and effectively signal maturation in the 
absence of Akt1 and Akt2.  Alternatively, Akt3 may activate distinct downstream 
signaling pathways that exert positive effects on early B cell survival and/or 
proliferation.  Clearly signals from Akt1 and Akt2 at these developmental stages 
are not required for development or survival of these cells.  This is in contrast to 
observations made in thymocyte development, in which a severe arrest occurs at 
the DN3 stage in Akt1/2 deficient thymocytes (Juntilla, Wofford et al. 2007).  
These differences may reflect Akt3 expression pattern variations as Akt3 is 
expressed at detectable levels in early B cells, but down regulated dramatically in 
developing thymocytes.  In this model, the aggregate Akt signaling required to 
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generate T cells is not reached in the absence of Akt1 and Akt2, but is achieved 
for early B cells.  Alternatively, the phenotype could reflect the outcome of 
specific downstream targets of Akt3 vs Akt1 and/or Akt2 and their ability to 
support early B cell generation.  Examination of Akt 1-3 triple knockout B cells 
will be required to elucidate Akt3’s role in early B cell development.  Interestingly, 
I find that the BCR repertoire of Akt1/2 deficient B cells is altered with increased 
frequencies of λ+ cells, in both mature and immature B cell subsets, these 
observations are in agreement with CD19 deficient B cells, which also display 
increased frequencies of λ+ cells across immature and mature B cells subsets 
(Diamant, Keren et al. 2005).  The increased λ+ frequency could represent 
changes in BCR selection as a result of altered BCR complex signaling 
outcomes during development in the absence of Akt.  A notion supported by our 
in-vitro data illustrating defective proliferative responses to BCR cross-linking.  
Alternatively, Akt signaling could be important in shutting down Rag transcription 
as observed by Amin and colleagues (Amin and Schlissel 2008) as such it is 
possible that cells in the pro and immature B cell stages can not properly 
regulate Rag, resulting in continued expression and exhaustion of the κ locus 
and eventual progression to the λ locus.  
 In the periphery, B1 and MZ B cells are thought to be a selected pool, 
requiring stronger signals through the BCR (Lopes-Carvalho and Kearney 2004), 
given the ability of CD19 to increase the sensitivity of the BCR signaling 
(Fujimoto, Poe et al. 2002) it is possible that the loss of MZ and B1 B cells in Akt 
1/2 DKO chimeras reflects an inability to generate the “proper” strength of signal 
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through the BCR-CD19 complex.  I can conclude that the block in MZ 
development is not the result of poor survival, as ectopic expression of Bcl-xL 
was unable to rescue development of these cells.  Interestingly, it was previously 
reported that a Bcl-2 transgene could rescue MZ development in CD19 deficient 
animals (Otero, Anzelon et al. 2003).  These data suggest that Akt may be 
required in both a CD19 dependent and independent manner during the 
generation of MZ B cells.  Furthermore, Suzuki et al. demonstrated that a Bcl-xL 
transgene could rescue B220+ cells in PI-3K deficient splenocytes, however 
these workers did not subset B cell populations and thus the MZ B cell 
compartment was not examined (Suzuki, Matsuda et al. 2003).  It should be 
noted that numerous receptors possess the capacity to activate PI-3K and hence 
Akt, including but not limited to chemokine, cytokine, toll-like and co-stimulatory 
receptors (Fruman, Snapper et al. 1999; Jou, Carpino et al. 2002; Okkenhaug 
and Vanhaesebroeck 2003; Donahue, Hess et al. 2004; Fruman 2004).  One 
such pathway I explored was the Notch pathway, previously shown to activate 
Akt in developing thymocytes (Ciofani and Zuniga-Pflucker 2005; Palomero, Sulis 
et al. 2007).  My results indicate that the presence of a constitutively active form 
of Akt selectively expressed in mature B cells failed to rescue MZ development in 
the presence of DNMAML, suggesting that any potential Notch-Akt signaling axis 
does not require activation of Akt to generate MZ B cells. 
 This similarity of developmental phenotypes and defective in-vitro 
proliferative responses of Akt1/2 deficient and CD19/PI-3K deficient animals 
supports the hypothesis that Akt is a critical downstream target of the PI-3K in 
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the context of B cell development and activation.  Clearly, additional experiments 
addressing the potential of myr-Akt to rescue the CD19 deficient phenotype or 
assessment of positive/negative selection of BCRs with heavy chain transgenic 
systems will be required to more definitively demonstrate the role of Akt1/2 
downstream of the BCR/CD19 in the context of B cell development. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16:  Akt1/2 in B cell development.  Akt1 and Akt2 while dispensable for the 
generation of early bone marrow B cells is required for normal cell numbers and lambda 
frequencies, suggesting altered receptor editing.  Akt1/2 signals are required for the 
generation of MZ and B1a cells and to a lesser extent B1b and FOL B cell numbers.  Akt1/2 
are critical in the competitive fitness of FOL B cells, formation of the primary BCR repertoire, 
and proper responses to BCR mediated proliferation. 
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Chapter 4. Notch independent γ-secretase functions in B cell development 
and activation 
4.1 Introduction:  Role γ-secretase complex in lymphocytes.   
 The Notch pathway has a well documented role in the development of MZ 
B cells and though dispensable for the development of FOL B cells it does 
enhance their activation (Tanigaki, Han et al. 2002; Saito, Chiba et al. 2003; 
Hozumi, Negishi et al. 2004; Thomas, Calamito et al. 2007).  Notch signaling is 
initiated by receptor-ligand binding.  This binding enables metalloproteases to 
cleave the extracellular domain of the Notch receptor and leads to ectodomain 
shedding.  Shedding opens the remaining intramembrane region of the Notch 
receptor to be cleaved by the γ-secretase complex, freeing the intracellular 
domain of Notch to translocate to the nucleus and activate Notch target genes 
(Maillard, Fang et al. 2005).  While Notch is a critical target of γ-secretase activity 
in MZ B cell development, numerous reports demonstrate the importance γ-
secretase activity on signaling pathways independent of Notch  (Citron, Vigo-
Pelfrey et al. 1994; Kopan and Ilagan 2004; Parks and Curtis 2007; Hass, Sato et 
al. 2009; Li, Wolfe et al. 2009).  Perhaps the best example is the amyloid 
precursor protein (APP), which when mutated, promotes the formation of a 42 
amino acid γ-secretase cleavage product at the expense of the normal 40 amino 
acid product.  This larger cleavage product more readily forms plaques and is 
associated with early onset Alzheimer’s disease (Citron, Vigo-Pelfrey et al. 
1994).  The γ-secretase complex is a multi-protein membrane-imbedded aspartyl 
protease, consisting of four proteins: Presenilin, Presenilin enhancer (PEN2), 
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Nicastrin, and Anterior Pharynx-Defective-1 (Aph-1) (Li, Wolfe et al. 2009). The 
catalytic activity of γ-secretase, which is contained in the PS1 and PS2 proteins, 
drives the cleavage of a large number of single-pass transmembrane proteins of 
which over 80 substrates have been identified (Parks and Curtis 2007; Li, Wolfe 
et al. 2009).  The large number of γ-secretase targets has caused it to be loosely 
referred to as the “proteasome of the membrane” (Kopan and Ilagan 2004). To 
add an additional layer of complexity, γ-secretase can be isolated from the 
plasma membrane, the endoplasmic reticulum and the golgi, potentially 
implicating it’s function in a diverse array of cellular processes.  These 
observations raise the possibility that the γ-secretase complex could play both 
Notch dependent and Notch independent roles in B cell development and 
activation.   
 Two recent publications have elucidated a role for the catalytic 
components (Presenilin 1 and Presenilin 2) of the γ-secretase complex, in the 
development of thymocytes and MZ B cells (Laky and Fowlkes 2007; Yagi, 
Giallourakis et al. 2008).  However, these studies did not differentiate between 
Notch dependent and Notch independent functions of Presenilin proteins.  
Indeed, their respective observations are in agreement with Notch loss of 
function approaches suggesting that the loss of Presenilins and thus γ-secretase 
activity alters T and B cell development at the expected stages, yet the 
decreased calcium mobilization in splenocytes activated through the BCR in 
Presenilin deficient B cells (Yagi, Giallourakis et al. 2008) is not observed in B 
cells with a Notch loss of function (Tanigaki, Han et al. 2002). To clarify these 
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issues, I examined B cell subset development and BCR and TLR-mediated B cell 
activation upon deletion of PS1 and/or PS2 or inhibition of Notch activity in 
developing and mature B cells. Our studies suggest that Presenilins promote B 
cell activation, B1 B cell development, and establishment of the primary BCR 
repertoire without engagement of the Notch pathway.  
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4.2 Chapter 4 Results. 
4.2.1 Optimal BCR mediated proliferation requires γ-secretase in a Notch 
independent manner.  
 Recent studies from this lab demonstrated a role for γ-secretase activity in 
B cell activation through a synergistic effect of the γ-secretase substrate Notch 
and BCR (Thomas, Calamito et al. 2007). These experiments utilized a co-
culture system in which B cells were added to OP9 stromal cells engineered to 
express the Notch ligand Delta-like 1 (OP9-DL1). Given that splenic B cells 
express mRNA for DL1 (Hozumi, Negishi et al. 2004), one possibility is that BCR-
induced B cell proliferation is amplified via interactions between Notch2 and DL1 
on neighboring B cells.  To address this possibility I first tested addition of γ-
secretase inhibitor (GSI, compound E) to purified CFSE-labeled B cells 
stimulated with anti-IgM antibody or TLR ligand and measured proliferation in 
vitro. After 3 days in culture, GSI treated cells demonstrated significantly reduced 
proliferation to various concentrations of anti-IgM antibody (Fig. 17A). Notably, 
this effect was specific to stimulation through the BCR, as proliferation in 
response to LPS and CpG was not significantly altered (Fig. 17B). Importantly, 
exposure of CD23+ B cells to GSI was not toxic to B cells when compared to 
vehicle controls (Fig. 17C). 
Because multiple γ-secretase substrates outside the Notch pathway have 
been identified, I next sought to test whether specific inhibition of Notch activity 
also diminished BCR-induced proliferation. To this end, I harvested follicular B 
cells from mice carrying an inducible (Cre-dependent) allele encoding a dominant 
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negative version of the Notch/CSL coactivator MAML1 in the Rosa26 locus. This 
dominant negative form of MAML1, termed DNMAML1, recapitulates all known 
loss-of-function mutations associated with the Notch pathway in the 
hematopoietic system, and is expressed as a GFP fusion protein upon Cre-
mediated deletion of a transcriptional stop cassette in the Rosa26 promoter (Tu, 
Fang et al. 2005). Nearly half of follicular B cells from Rosa26+/DNMAML1-GFP mice 
pulsed with purified Tat-Cre fusion proteins and rested for 16 hours became 
GFP+ (Fig.18A).  This approach allowed me to examine the impact of DNMAML1 
expression in isolated B cells without potential complications arising from 
inhibiting Notch activity during B-lineage development and selection in the BM. 
Thus, GFP+ and GFP- CD19+ cells from Tat-Cre cultured Rosa26+/DNMAML1-GFP B 
cells were stimulated with increasing doses of anti-IgM or the TLR4 agonist LPS 
with or without addition of GSI. Three days later cells were pulsed with 3H-
thymidine. As shown (Fig. 18B), inhibition of CSL-dependent Notch signals had 
no affect on BCR-induced proliferation across increasing doses of anti-IgM 
antibody. Significantly however, exposure of both GFP+ and GFP- cells to GSI 
resulted in a dramatic drop in 3H-thymidine incorporation (Fig. 18B, D). 
Furthermore, I also observed normal BCR-induced proliferation in follicular B 
cells harvested from CD19+/Cre Rosa26+/DNMAML1-GFP mice (not shown). Altogether, 
these data further demonstrate that γ-secretase activity is required for optimal B 
cell proliferation in response to BCR cross-linking, and indicate that γ-secretase 
promotes optimal BCR signaling independently of CSL mediated Notch activity  
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Figure 17.  γ-Secretase inhibitors diminish BCR-mediated proliferative responses (A) 
CFSE-labeled CD23+ follicular B cells Ire stimulated with increasing concentrations (as 
indicated) of anti-IgM antibody (DMSO/black line) or γ-secretase inhibitor (100nM GSI, 
dotted line)  (B)  Cells isolated as in (A) stimulated with LPS (1µg/ml) or CpG (0.1µM) 
(DMSO/black line) or (GSI, dotted line).  (C)  CD23+ splenic B cells cultured in-vitro for 24hrs 
in the indicated doses of GSI and viability assessed. 
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Figure 18:  GSI diminishes BCR mediated proliferation is Notch independent.  (A)  
CD23+ splenic B cells from Rosa26+/DNMAML-GFP mice were pulsed with Tat-Cre for 16 hours 
before sorting DAPI- B220+ GFP+ and DAPI- B220+ GFP- cells. (B) 3[H]-thymidine uptake by 
sorted GFP+ or GFP – cells from (B) after three days stimulation with the indicated doses of 
anti-IgM antibodies or LPS (1µg/ml). Solid black bar, GFP-; solid white bar, DNMAML-GFP+; 
solid grey bar, DNMAML-GFP– plus 100nM GSI. (C) 3[H]-thymidine uptake by sorted GFP+ 
or GFP – from (B) treated for three days in the presence of 12.5µg/ml anti-IgM. Bars as in 
(C) except the grey bar with black shading indicates DNMAML-GFP+ cells cultured with GSI. 
Results are representative of 2-3 separate experiments. 
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4.2.2  Presenilins promote optimal BCR but not TLR-induced proliferation.  
 Given that GSI negatively affects anti-IgM but not LPS or CpG-induced B 
cell proliferation when added to wild type or Notch-inhibited (DNMAML1-GFP+) B 
cells (Fig. 17 and 18), I tested whether B cells lacking the catalytic components 
of γ-secretase exhibit suboptimal proliferative responses to BCR cross linking 
and whether this effect is unique to the BCR. In this regard, one recent study 
from Yagi et al. showed that B cells lacking Presenilin 1 (PS1) and Presenilin 2 
(PS2) fail to enter the cell cycle upon either anti-IgM or LPS stimulation (Yagi, 
Giallourakis et al. 2008). However I find that GSI fails to impact B cell 
proliferation in response to LPS or CpG stimulation (Fig. 17). To address these 
issues I first generated C57BL/6-backcrossed CD19+/Cre mice harboring two 
floxed PS1 alleles and two null alleles for PS2. For simplicity I will refer to the 
resulting CD19+/Cre PS1f/f PS2-/- mice as PS1/2 DKO mice throughout this 
dissertation.  
To clarify the cell-intrinsic role of Presenilins in BCR and TLR-mediated B 
cell proliferation, I mixed CFSE-labeled CD23+ splenic B cells from PS1/2 DKO 
(Ly5B6) and wild type B6.Ly5SJL mice at a 3:1 ratio of PS1/2 DKO and wild type 
cells, and stimulated these cells with increasing doses of anti-IgM antibodies or 
LPS or CpG. After three days of stimulation with multiple doses of anti-IgM 
antibodies, wild type (Ly5SJL+) B cells grew to dominate these cultures (Fig. 19A). 
Further, examination of CFSE dilution curves for each population revealed that a 
substantially smaller number of PS1/2 DKO B cells completed one or more 
rounds of cell division compared to wild type cells cultured under identical 
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conditions. Indeed, after three days cell recoveries for PS1/2 DKO B cells were 
10-fold lower than wild type cells, whether such cells were mixed before 
stimulation or cultured separately (Fig  20A,B). Furthermore, addition of GSI to 
PS1/2 DKO B cells did not result in additional decreases in anti-IgM induced 
proliferation, indicating that GSI specifically inhibits Presenilins activity in this 
context (Fig. 20C). However, proliferative responses of PS1/2 DKO B cells upon 
LPS or CpG stimulation were unchanged relative to wild type controls (Fig. 19B). 
These data show that γ-secretase activity is required for optimal BCR-mediated 
but not TLR-mediated B cell activation, and contrast with a recent study 
suggesting that Presenilins regulate responsiveness to TLR ligands such as LPS.  
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Figure 19: Presenilins promote BCR but not TLR induced proliferation in follicular 
B cells. (A) Ly5B6+ (PS1/PS2 DKO) and Ly5SJL+ (control) CD23+ splenic B cells Ire 
CFSE labeled, mixed at a 3:1 ratio, and stimulated with the indicated doses of anti-IgM 
antibody for three days (top panel). Plots gated on live (DAPI-) cells. Histograms 
illustrate CFSE dilution curves for PS1/PS2 DKO (black) versus wild type (grey) cells for 
the corresponding dose of anti-IgM antibodies. (B) CFSE-labeled CD23+ splenic B cells 
cultured with LPS (1µg/ml) or CpG (0.1µM) for three days. Plots gated on live (DAPI-) 
cells, PS1/PS2 DKO (black) versus wild type (grey). Representative of three 
experiments. 
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Figure 20.  Presenilin proteins are required for optimal BCR mediated proliferation.  (A) 
Viable cell recoveries of Ly5SJL+ (black) or Ly5B6+ CD19+/Cre PS1f/f  PS2-/- (white) CD23+ cells in 
a mixed in-vitro culture after three days. (B) Viable cell recoveries of CD19+/Cre PS1+/+ PS2+/+ 
(black) or CD19+/Cre PS1f/f  PS2-/- (white) after three day in-vitro culture, representative of four 
experiments. (C) CFSE-labeled CD23+ splenic B cells from CD19+/Cre PS1f/f  PS2-/- mice were 
cultured in-vitro for three days in the presence of vehicle control (solid black line) or 100nM 
GSI (red line) 
 77 
4.2.3  Compromised calcium mobilization in Presenilin deficient B cells.  
 Increases in intracellular calcium levels enact a diverse range of functions 
and occur due to the induced release of calcium from the endoplasmic reticulum 
(ER), and the subsequent intake of extracellular calcium through channels in the 
plasma membrane in response to depletion of ER calcium stores (Scharenberg, 
Humphries et al. 2007; King and Freedman 2009). A wealth of data indicate that 
Presenilins regulate the release and utilization of calcium from the endoplasmic 
reticulum (ER) in neurons (Cai, Lin et al. 2006; Tu, Nelson et al. 2006; Cheung, 
Shineman et al. 2008) and recent data indicate that Presenilin-deficient 
thymocytes exhibit compromised calcium mobilization upon aggregation of the T 
cell receptor (Laky and Fowlkes 2007). To test whether diminished BCR-induced 
B cell activation correlates with suboptimal calcium responsiveness, I isolated 
CD23+ splenic B cells from PS1/PS2 DKO mice as Ill as CD19+/Cre and CD19+/Cre 
Rosa26+/DNMAML1-GFP controls, labeled these cells with Indo-1AM, and added anti-
IgM cross linking antibodies.  
In media containing free calcium I observed delayed and marginally 
decreased calcium mobilization in PS1/PS2 DKO B cells relative to all controls 
including GFP+ cells from CD19+/Cre Rosa26+/DNMAML1-GFP mice (Fig. 21A). As 
expected, calcium mobilization was not depressed in Notch-inhibited B cells. 
Indeed, in many experiments DNMAML1-GFP+ B cells exhibited a slightly 
increased calcium response (Fig 21A). To test directly whether Presenilins 
regulate calcium release from the ER, I chelated extracellular calcium by adding 
EGTA before aggregation of the BCR. As shown (Fig. 21B), PS1/PS2 DKO B 
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cells displayed a modest but consistent decrease in ER calcium store release 
upon BCR stimulation 
With separate samples I also tested whether Presenilins influence the 
intake of extracellular calcium by adding thapsigargin, which depletes ER calcium 
stores by blocking SERCA pumps in the ER. As shown (Fig. 21C), CD19+/Cre 
control and PS1/PS2 DKO B cells exhibited similar levels of calcium uptake after 
adding thapsigargin, suggesting that Presenilins do not play a major role in 
calcium homeostasis downstream of the ER. Furthermore, initial calcium levels 
within the ER of unstimulated cells appeared normal, as baseline calcium levels 
were comparable for CD19+/Cre and PS1/PS2 DKO B cells (Fig. 21A, B), and in 
mutant and control samples increases in intracellular calcium levels were not 
significantly different upon adding thapsigargin in the presence of EGTA (Fig. 
21D). These data are consistent with the notion that Presenilins promote the 
BCR-mediated release of intracellular calcium stores from the ER.  
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FIGURE 21.  Presenilins promote optimal BCR-induced ER Ca2+ release. (A) Mean 
of calcium mobilization measurements in Indo-1AM loaded CD23+ splenic B cells 
isolated from control (solid black line), PS1/PS2 DKO (solid grey line), and CD19+/Cre 
Rosa26 +/DNMAML-GFP (dashed grey line) after stimulation with 15µg/ml anti-IgM antibody 
in calcium-containing media. (B) Calcium mobilization cells isolated and stimulated as in 
(A) in the presence of 12.5 mM EGTA. (C) Calcium mobilization analysis of cells 
isolated as in (A) treated with 1µM thapsigargin in calcium-containing media. (D) 
Analysis of calcium mobilization in cells isolated as in (A) and stimulated with 1µM 
thapsigargin in the presence of 12.5 mM EGTA. 
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4.2.4  Presenilins are critically required for the development of B1 B cells. 
 Previous reports suggest that enhanced BCR signaling drives the 
formation of B1 B cells (Lam and Rajewsky 1999; Casola, Otipoby et al. 2004). 
Given that PS DKO B cells exhibited suboptimal responsiveness to BCR 
aggregation, I assessed frequencies of all peripheral B cell subsets including B1 
B cells in the peritoneal cavity of mice lacking PS1 and PS2 or either PS1 or PS2 
alone. Consistent with the expected loss of Notch2 function, the splenic MZ B cell 
pool was markedly decreased in PS1/PS2 DKO mice (Fig 22A). In addition, 
frequencies of immature transitional and mature follicular B cells in the spleen 
and B-lineage progenitors in the BM were unaffected, although I consistently 
noted a decline in surface CD21 levels in PS1/PS2 DKO B cells as reported to 
occur in Notch-deficient B cells (Saito, Chiba et al. 2003), and I also noted an 
unexplained decline in surface CD23 levels as recently noted upon enforced 
survival of mature B cells lacking a BCR (Figure 22B) (Srinivasan, Sasaki et al. 
2009).  
In the peritoneal cavity PS1 and PS2-deficient mice as well as PS1/PS2 
DKO mice exhibited a significant decline in frequencies of all CD19+ B220low 
CD43+ B1 B cells (Fig. 23A). Furthermore, whereas both B1a (CD5+) and B1b 
(CD5-) cells, the two chief subsets of B1 B cells (Dorshkind and Montecino-
Rodriguez 2007), were equally compromised in PS1- and PS2-deficient mice, 
frequencies of B1a cells were especially depressed in PS1/PS2 DKO mice (Fig. 
23A). Notably and consistent with past studies, Notch inhibition did not affect the 
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size of the B1 pool (Fig. 23B). I conclude that Presenilins promote B1 B cell 
development independently of the Notch pathway.  
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Figure 22. Impact of loss of Presenilins on splenic B cell subset composition. (A) 
Splenic B cells from CD19+/Cre PS1+/+ PS2+/+ (far left), CD19+/Cre PS1f/f PS2+/+ (second from 
left), CD19+/+ PS1+/+  PS2-/- (third from left), or CD19+/Cre PS1f/f  PS2-/- (far right) were stained 
with the indicated antibodies before analysis of 250,000 events on an LSR2 flow cytometer. 
(B) Overlay histograms for the indicated surface proteins. Cells were gated on IgMint CD21+ 
follicular B cells as shown in (A).  Black CD19+/Cre PS1 +/flox PS2+/-, Red CD19+/Cre PS1 flox/flox 
PS2+/+, Blue CD19+/+ PS1 +/+ PS2-/-, Purple CD19+/Cre PS1 flox/flox PS2-/-. Data are 
representative of at least three animals per group and two separate experiments. 
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Figure 23. Defective B1 B cell development without Presenilins. (A) Peritoneal cavity 
lymphocytes from the indicated mice were stained with the indicated antibodies before collection 
of 100,000 events on an LSR2 flow cytometer. The left-most plots are gated on viable B cells 
(DAPI- CD19+). Numbers in plots show the frequency of events as a function of the indicated 
parent gate. Representative of at least three animals per group and two separate experiments. 
(B) Peritoneal cavity lymphocytes from the indicated additional 12-week old mice were stained 
and analyzed as in (A). All panels gated on DAPI- CD19+ cells, CD19+/Cre Rosa26+/DNMAML-GFP 
mice were also gated on GFP+ cells. Representative of three separate experiments.   
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4.2.5  The absence of Presenilin proteins leads to decreased λ+ B cells. 
 Defects in B1 development, compromised anti-IgM proliferative 
responses, and altered Ca+ collectively suggest that Presenilins potentiate 
optimal BCR signaling. Hence, given that tonic BCR signaling plays a 
fundamental role in formation and maintenance of the primary BCR repertoire, I 
reasoned that Presenilins might also play a role in BCR repertoire selection. 
Consistent with this possibility, mature splenic B cells (CD19+ AA4-) revealed a 
dramatic decrease in the percentage of λ+ B cells (Fig. 24A). The ratio of mature 
B cells bearing κ versus λ light chains was raised from 19.61+/- (.35) in controls 
to 50.32 +/- (4.9) in PS DKO B cells (Table 4). The decrease in λ+ B cells was 
also detected in the splenic transitional B cell pool (CD19+ AA4+) from PS1/PS2 
DKO mice, suggesting that the generation of λ+ B cells is defective in the 
absence of Presenilin proteins.  Similar observations were evident with the loss 
of a single isoform of Presenilin 1 or Presenilin 2 (Fig. 24A & Table 4). Further, 
examination of the BM, spleen and peritoneal cavity B cell pools demonstrated 
decreased frequencies of λ+ B cells across all tissues in the absence of 
Presenilins (Fig. 25). In contrast, frequencies of λ+ B cells in CD19+/Cre 
Rosa26+/DNMAML-GFP mice did not differ from the CD19+/Cre controls across all B 
cell subsets (Fig. 25). These data indicate that Presenilins play a fundamental 
role in shaping BCR repertoire without engaging the Notch pathway.   
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Figure 24. Generation of λ-chain positive B cells with and without Presenilins. 
(A) Splenocytes from 12-week old mice of the indicated genotypes were stained with 
the indicated antibodies before collection of 300,000 events on an LSR2 flow 
cytometer. The left-most panels are gated on DAPI- cells, and the indicated parent 
gates were used to examine frequencies of l+ cells in transitional and mature B cells. 
Flow plots representative of at least three animals per group.. All data representative 
of three separate experiments. 
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Figure 25.  Decrease in λ-chain positive cells is Notch independent and occurs within 
the immature bone marrow B cell compartment.  Representative flow cytometric data of 
BM immature (CD19+ IgMhigh AA4+, left column), mature splenic (CD19+ AA4-, center 
column), and peritoneal cavity B1 (CD19+ CD43+, right column) B cells from the indicated 
mice. All plots also gated on viable (DAPI-) cells. For (A) and (B) numbers within plots 
represent the frequency of events as a function of the indicated parent gate 
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Table 4. Altered kappa/lambda ratios in Presenilin-deficient mice 
B Cell Subset Genotype % λ % κ Ratio κ/λ 
Immature CD19+/Cre PS1+/+ PS2+/+ 8.12 
(.37) 
85.80 
(.85) 
10.62 
(.60) 
 CD19+/Cre PS1f/f PS2+/+ 4.40 
(.96) 
80.13 
(7.68) 
20.66 
(5.64) 
 CD19+/+ PS1+/+ PS2-/- 6.28  
(2.48) 
70.76  
(7.02) 
15.59 
(5.75) 
 CD19+/Cre PS1f/f PS2-/- 2.79 
(.26) 
78.58 
(4.76) 
28.97 
(2.65) 
     
Mature CD19+/Cre PS1+/+ PS2+/+ 4.75 
(.07) 
93.13 
(.20) 
19.61 
(.35) 
 CD19+/Cre PS1f/f PS2+/+ 1.39 
(.35) 
88.43 
(6.17) 
70.37 
(13.58) 
 CD19+/+ PS1+/+ PS2-/- .95 
(.13) 
79.73 
(6.21) 
85.47 
(7.27) 
 CD19+/Cre PS1f/f PS2-/- 1.71 
(.14) 
84.08 
(5.10) 
50.32 
(4.9) 
 
 
Immature B cells (CD19+ AA4+) and mature B cells (CD19+ AA4-) were gated as shown in Figure 
20A.  Percentages are means foe 3-5 animals per group, SEMs are indicated within parentheses. 
Ratio calculated by dividing the frequency of κ+ cells by the frequency of λ+ cells for each B cell 
subset.   
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4.3  Chapter 4 Summary-Brief Discussion 
 In this chapter I demonstrate that FOL B cells co-cultured with GSI exhibit 
decreased proliferative responses to BCR cross-linking, furthermore I show that 
GSI is not overtly toxic to B cells.  Previous studies documented a similar 
phenotype in T-cells stimulated through the T cell receptor (TCR) in the presence 
of GSI, leading to the interpretation that the Notch pathway was critical to TCR 
mediated proliferation (Palaga, Miele et al. 2003).  Given that the γ-secretase 
complex can catalyze the cleavage of multiple single pass transmembrane 
proteins I sought to examine the involvement of the Notch pathway in GSI treated 
B cell cultures.  To this end I employed an inducible DNMAML construct, and 
demonstrate that canonical Notch signaling is dispensable for normal BCR driven 
proliferation.  This observation does not contradict previous work from our lab 
highlighting a role for the Notch pathway in enhancing BCR driven responses, as 
the data presented herein only rule out a requirement for the Notch pathway in B 
cell activation.   
 To extend our observations beyond inhibitor based studies I choose to 
utilize a loss of function approach in which the catalytic components of the γ-
secretase complex (Presenilins) were conditionally deleted from the B-lineage.  
Using FOL B cells from PS1 PS2 deficient mice I demonstrated a cell intrinsic 
defect in BCR responsiveness, especially at suboptimal doses of anti-IgM cross-
linking antibody.  These data demonstrate a role for Presenilin proteins in 
modulating BCR activation and agree with and extend the recent findings of Yagi 
et al.  In contrast to observations made by Yagi et al. I do not find that B cells 
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lacking Presenilin proteins exhibit defective proliferative responses to LPS 
stimulation (Yagi, Giallourakis et al. 2008).  A potential explanation for this 
inconsistency is that their data did not control for differences in splenic B cell 
subset composition in Presenilin-deficient and wild type control animals. Indeed, 
it is well established that MZ B cells are highly enriched for LPS-responsive cells 
(Oliver, Martin et al. 1997), and this population is absent from PS1/PS2 DKO B 
cell pools, presumable due to failed Notch2 activation. In contrast all experiments 
assessing B cell activation herein employed positively selected CD23+ B cells, 
which are highly enriched for FOL B cells and lack MZ B cells. Therefore I posit 
that the previous data suggesting that LPS responsiveness in B cells requires 
Presenilins instead reflect differences in B cell subset composition among 
Presenilin-deficient and control splenocytes.    
 Given the suboptimal BCR responsiveness of Presenilin deficient B cells I 
next examined calcium mobilization downstream of the antigen receptor.  My 
data suggests that the magnitude of the initial release of ER calcium stores is 
dampened in the absence of Presenilin proteins.  This observation is consistent 
with the notion that Presenilins modulate BCR signaling.  My observation that the 
B1 B cell compartment is dramatically reduced in Presenilin deficient mice also 
supports this hypothesis, as B1’s are thought to require stronger signaling 
through the BCR for their generation (Casola, Otipoby et al. 2004).  An 
alternative explanation for the dearth of B1 B cells in these mice is that the 
maintenance and not the generation per se of the B1 B cell pool is perturbed, 
such that the self-renewing capacity of the B1 pool is compromised.   
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 Finally, I observed that while FOL B cells develop in the absence of 
Presenilins, the BCR repertoire of this pool as indicated by the decreased 
frequency of λ+ cells, is altered.  Furthermore, this decrease in λ+ cells is 
observed within the immature B cell populations of the spleen and bone marrow 
suggesting that the generation and not the maintenance of λ+ bearing cells is 
defective in PS1/2 deficient cells. 
 In conclusion, this chapter provides the first evidence of a role for 
Presenilin proteins in the development, activation, calcium signaling and BCR 
repertoire formation of B-lymphocytes independent of the canonical Notch 
signaling pathway.  Clearly, future studies are required to dissect how the 
described phenotypes are dependent or independent of the enzymatic activity of 
Presenilin proteins.  Given that GSI is currently in clinical trials to treat Notch 
driven T-cell leukemia, my work emphasizes the need to further understand 
Presenilin and γ-secretase complex function in B cell biology.  
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Figure 26.  Role of Presenilins in B cell biology.  Presenilins are required for normal 
B1a, B1b and BCR repertoire development independent of the Notch pathway.  In 
addition, Presenilins promote BCR mediated proliferation and normal calcium mobilization 
in response to antigen receptor cross-linking.  Presenilin mediated cleavage of Notch 
drives the MZ B cell fate.   
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Chapter 5:  Overall Discussion 
 
5.1 Akt1 and Akt2 in bone marrow B cell development 
 
 In this thesis, I have shown that Akt1 and Akt2 are dispensable for the 
development of pro, pre, and immature B cells (Fig 5).  This result was in some 
ways surprising given the requirement for Akt1/2 dependent signals in analogous 
stages of thymocyte development (Juntilla, Wofford et al. 2007; Mao, Tili et al. 
2007).  The simplest explanation for my finding is that the remaining Akt3, is 
sufficient to promote the early stages of B cell development.  Indeed, I find Akt3 
mRNA in pro, pre and immature B cell populations (Fig 12), this is in contrast to 
thymocytes that express negligible levels of Akt3 mRNA and protein (Juntilla, 
Wofford et al. 2007).  A drawback of my study is that I did not examine Akt3 
protein expression of in these early B cell progenitors.  Therefore it remains to be 
seen if the Akt3 mRNA is actually translated into protein in these cells. These 
data would further support the hypothesis that Akt3 is sufficient to mediate early 
B cell development in the absence of Akt1 and Akt2.  An alternative explanation 
is that early B cell populations develop independently of Akt signaling in general.  
This notion is supported by the observation that deletion of molecules upstream 
of Akt activation, for example p110δ or CD19, contain intact pro, pre and 
immature B cell compartments in steady state animals (Rickert, Rajewsky et al. 
1995; Clayton, Bardi et al. 2002; Otero and Rickert 2003).  Clearly, an Akt 3 
single knockout as well as an Akt1-3 triple knockout will be required to more 
clearly define the role of Akt3 in bone marrow B cell generation.  Interestingly, a 
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B cell specific Akt1-3 deficient mouse has been generated and is currently being 
examined (Rickert,R personal communication).  
 The increased frequency and cell numbers of these early B cell pools is a 
peculiar phenotype given Akt’s positive regulation of cellular metabolism, survival 
and cell cycle.  If anything, I would expect these pools to be diminished with the 
loss of two Akt isoforms.  A potential explanation for this observation is that while 
Akt is dispensable for the survival of early B cells it is important for their 
developmental differentiation.  In this model, the absence of Akt1 and Akt2 leads 
to an inefficient transition from the immature to mature B cell pool by an unknown 
mechanism, perhaps activation of transcription factors downstream of Akt 
signaling.  For example, recent work demonstrates a role for Akt mediated 
degradation of the Forkhead (Foxo) family of transcription factors at the pro and 
immature stage of B cell development.  Foxo expression at these stages 
increases Rag transcription.  First pre-BCR and then mature BCR signaling at 
these respective stages activates Akt, causing Foxo degradation and cessation 
of Rag transcription (Amin and Schlissel 2008).  This predicts that in the absence 
of Akt1 and Akt2 Rag down-regulation is inefficient, and by extension the 
regulation of other genes critical to B cell development may be abnormal.  In turn 
this could lead to a slower developmental kinetic for B cells in the immature 
stage.  This notion is supported by three independent but related observations.  
First, BCR signaling at the immature stage of development activates PI-3K and is 
important for promoting positive selection (Verkoczy, Duong et al. 2007).  
Furthermore, immature B cells treated with PI-3K inhibitors display the capacity 
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for “back-differentiation,” i.e. expression of surface markers and genes typically 
associated with the pro and pre B cell stages of development (Tze, Schram et al. 
2005). Finally, mice deficient in p110δ or CD19 possess immature B cells with 
increased levels of Rag mRNA and contain an increased percentage of λ+ cells, 
thus PI-3K-Akt signaling may be critical to prohibiting receptor editing in positively 
selected B clones  (Diamant, Keren et al. 2005; Llorian, Stamataki et al. 2007).  
The immature B cell populations in chimeras established with Akt1/2 deficient 
progenitors have increased frequencies of λ+ cells, similar to CD19 deficient 
animals, suggesting enhanced receptor editing; possibly the result of crippled 
BCR positive selection in the absence of Akt1 and Akt2.  If Akt1/2 deficient 
immature B cells are not signaling differentiation efficiently then they might be 
susceptible to the “back-differentiation” observed by Tze et al. and this may 
explain the increased percentage and numbers of cells found in the pro and pre 
B cell gates with flow cytometric analysis.  This model may also address the 
increased representation of Akt1/2 deficient B cells in competitive mixed fetal 
liver chimeras (Fig 9B). Assessment of turnover rates in the pro, pre and 
immature B cell compartments by Brd-U pulse-chase, will further understanding 
of the kinetics at which cells exit these respective pools.  My hypothesis is that if 
Akt signals promote efficient differentiation, then turnover rates in each 
respective compartment will be decreased.  In addition, if Akt regulates Rag 
expression, then sorted immature Akt1/2 deficient B cells should express 
increased Rag transcripts.  If these predictions hold true, one could speculate 
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that ectopic expression of an siRNA capable of Foxo knockdown might restore 
the bone marrow B cell compartment to normal proportions.   
 Recent data from Derudder et al. indicate that NF-kB deficiency leads to 
increased frequencies of pre-B cells (Kane, Shapiro et al. 1999; Derudder, 
Cadera et al. 2009). Given that Akt signaling promotes NF-kB activity in other 
contexts (Kane, Shapiro et al. 1999), the increased numbers of pre-B cells 
produced by Akt1/2 DKO progenitors may reflect decreased NF-kB activity in 
pro- and/or pre-B cells. Thus experiments testing whether enforced NF-kB 
activity decreases numbers of pre-B cells and increases numbers of MZ and B1 
B cells in the context of Akt deficiency might provide important information 
concerning the mechanism of Akt-dependent development and selection within 
B-lineage precursors in the marrow.  
 Finally, an alternative explanation for the increased frequency of λ-bearing 
cells within the immature B cell compartment, is that Akt signaling influences the 
accessiability of the RAG complex to the light chain loci. In this model the altered 
κ/λ ratio is a product independent of selection mediated by the BCR, but instead 
reflects defective cytokine or receptor-ligand interactions critical for opening the 
κ-locus or repressing the λ-locus.   
 
5.2 Normal B1 and MZ B cell development requires Akt1 and Akt2. 
 I find that B1a and MZ B cell development is blocked, and B1b 
development is diminished in the absence of Akt1 and Akt2 (Fig 6 & 7).  These 
findings are consistent with previous reports demonstrating a lack of B1 and MZ 
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B cells in mice deficient for CD19 or components of the PI-3K pathway, 
suggesting that Akt is a critical downstream target of these molecules.  In 
addition, these data demonstrate that Akt3 alone is insufficient to mediate 
development of these subsets.  This may reflect the decreased expression of 
Akt3 in MZ and B1s relative to the FOL pool (Fig 12) such that the required 
aggregate Akt signaling does not reach a required threshold.  Alternatively, the 
results may indicate that Akt1 or Akt2 can regulate downstream pathways that 
Akt3 does not in the context of B1 and MZ development.  Furthermore, I 
observed an increased frequency of MZ B cells among naïve CD19+ B cells, in 
mice engineered to conditionally express a constitutively active form of Akt (Myr-
Akt) in the mature B-lineage (Fig 15A).  Collectively, these data demonstrate the 
importance of the Akt pathway in B1a and MZ B cell development, and indicate a 
non-redundant role for Akt1 and Akt2 in the peripheral B cell compartment.   
 Given Akt’s capacity to regulate a diverse number of biochemical 
pathways, I questioned what the mechanistic function of Akt is for MZ B cell 
development.  Studies by Otero et al demonstrated that MZ B cell development 
in CD19 deficient animals could be rescued by transgenic expression of the pro-
survival molecule Bcl-2 (Otero, Anzelon et al. 2003).  The similarities between 
CD19 deficient and Akt1/2 deficient B cells to this point were striking, so I 
decided to test the hypothesis that survival was the critical downstream effect of 
CD19-Akt signaling.  To this end, I transduced Akt1/2 deficient fetal liver 
progenitors with Bcl-xL.  While ectopic expression of Bcl-xL enhanced frequencies 
of recirulcating B cells in the bone marrow, it was not sufficient to rescue MZ B 
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cell development in the absence of Akt1 and Akt2 (Fig 13).  It is possible that my 
retro-viral approach did not produce sufficient levels of Bcl-xL to mediate rescue.  
However, I can offer indirect evidence of the constructs efficacy; first it was able 
to mediate increases in mature bone marrow B cells (Fig 13A).  Second, in-vitro 
assays demonstrated that cells expressing Bcl-xL survived radiation induced 
apoptosis again suggesting the construct afforded a survival advantage (not 
shown).  If I accept that the Bcl-xL construct had efficacy, then the discrepancy 
between our findings and Otero et al could reflect inherent differences in the 
functions of Bcl-2 vs. Bcl-xL.  This possibility will need to be addressed in future 
experiments.  Should enforced expression of Bcl-2 fail to rescue the MZ lineage 
in an Akt1/2 deficient background it raises the prospect of CD19 independent 
functions for Akt.  Given that the BCR can transiently activate Akt this is a likely 
possibility (Li, Davis et al. 1999).  Crossing B lineage restricted Myr-Akt mice 
onto the CD19 deficient background, followed by an assessment of MZ and B1 
development should help to elucidate the Akt dependent functions of CD19.   
 Notch receptor signaling has the potential to activate Akt in T  cells and B 
cells, and is absolutely required for MZ B cell generation (Tanigaki, Han et al. 
2002; Saito, Chiba et al. 2003; Maillard, Weng et al. 2004; Ciofani and Zuniga-
Pflucker 2005; Thomas, Calamito et al. 2007).  To determine if Myr-Akt could by 
pass the Notch requirement for MZ B cell development I introduced a dominant 
negative MAML construct, capable of inhibiting all canononical Notch signaling, 
into B lineage restricted Myr-Akt expressing cells.  These data show that Myr-Akt, 
while sufficient to increase the frequency of MZ B cells in a wild-type background, 
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is insufficient to rescue MZ B cell development in the absence of Notch signaling 
(Fig 15B).  Therefore, Notch in all likelihood activates pathways in addition to Akt 
and perhaps these either independently or combined can regulate Notch’s effect 
on MZ B cell development.  It is worth noting that Moran et al found a genetic link 
between the NFκB and the Notch pathway (Moran, Cariappa et al. 2007), and 
perhaps future studies could place an NFκB gain of function approach on a 
Notch loss of function and examine the effect on MZ B cell biology. 
 I also examined cell size as a crude measure of metabolic fitness in Akt1/2 
deficient FOL and transitional B cell subsets, and found no difference in 
comparison to wild-type cells, suggesting that poor metabolism was not 
responsible for the block in MZ development.   
 B1 and MZ B cells pools are positively selected on self-ligand or strong 
tonic signals, and Akt may play an important role in this process.  Indeed, BCR-
CD19 activation mediates positive selection events in the periphery (Martin and 
Kearney 2000; Diamant, Keren et al. 2005).  Furthermore, mice deficient in 
PTEN have increased frequencies of B1 and MZ, and possess FOL B cells that 
fail negative selection in tolerance models (Anzelon, Wu et al. 2003; Browne, Del 
Nagro et al. 2009).  These observations, coupled with the fact that Akt is 
downstream of the BCR (Otero, Omori et al. 2001), suggest that Akt derived 
signals are critical to negative and positive selection in the periphery.  Indeed, I 
observe a change in the peripheral BCR repertoire as indicated by an increased 
frequency of λ+ naïve FOL B cells (Fig 11).  Furthermore, I find that proliferative 
responses to BCR cross-linking on mature B cell in Akt1/2 deficient splenocytes 
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are defective (Fig 8), further supporting that the B cell abnormalities observed in 
Chapter 3 of this thesis reflect crippled BCR signaling in the absence of Akt1/2.   
 In mice deficient in the tyrosine phosphatase CD45 (a positive regulator of 
BCR signaling), B cells expressing an Ig transgene with specificity for hen egg 
lysozyme (HEL) are positively selected in the presence of soluble antigen, in 
contrast to wild-type Ig HEL+ B cell which are rendered anergic in this system 
(Cyster, Healy et al. 1996).  It would be interesting to breed the Ig HEL+ 
transgenic BCR onto Akt1/2 deficient soluble and membrane bound HEL 
expressing mice and examine the fate of peripheral Ig HEL recognizing clones.   
 
5.3 Akt 1 and Akt2 are critical for the competitive fitness of peripheral B 
cell populations. 
 Decreased FOL B cell numbers, poor survival in-vitro, and a block in B cell 
populations that require stronger BCR signals suggested that Akt1/2 deficient 
progenitors may be weak competitors in mixed marrow chimeras.  Indeed, the 
absence of Akt1 and Akt2 resulted in an absolute defect in the ability to generate 
MZ or marginal zone precursor (MZP), furthermore a paucity of donor derived 
cells were represented within the FOL B cell pool when matched with wild-type 
competitors (Fig 9).  This data is reminiscent of competitive chimeras in which 
mice deficient in Btk or CD19 were matched with wild-type cells (Sprent and 
Bruce 1984; Otero, Anzelon et al. 2003).  These data show that Akt is critical to 
the competitive fitness of peripheral B cell populations, and demonstrates an 
inability to efficiently gain access to or utilize resources crucial to survival.  I 
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noticed that Akt1/2 deficient B cells started loosing representation as early as the 
T2 stage of peripheral B cell development.  Interestingly, it is at this stage that 
BR3 is up-regulated and begins to govern the size of the peripheral B cell pool 
(Stadanlick, Kaileh et al. 2008).  Given that Blys-BR3 signaling can activate Akt 
(Patke, Mecklenbrauker et al. 2006; Otipoby, Sasaki et al. 2008; Woodland, Fox 
et al. 2008) I decided to explore the ability of Akt1/2 deficient FOL B cells to 
respond to Blys, finding that these cells do infact respond to Blys (Fig 10A).  This 
observation suggests that Akt3 may be sufficient for Blys mediated survival, 
alternatively, the Akt pathway while activated by Blys does not mediate survival 
functions downstream of this pathway.  It is interesting to note that BR3 
deficiency does not lead to defects in the B1 pool (Lentz, Hayes et al. 1998), but 
Akt1/2 deficient chimeras do show B1 abnormalities. Furthermore, enforced 
expression of Bcl-xL was previously shown to enhance the MZ compartment in 
BR3 deficient mice (Amanna, Dingwall et al. 2003).  If a BR3-Akt axis was critical 
to the maintenance of MZ B cells my over-expression of Bcl-xL should have 
rescued this population.  These observations, coupled with in-vitro data, allows 
me to make the general conclusion that Akt1 and Akt2 are not the principle 
mediators of survival downstream of Blys signaling.  Perhaps an assessment of 
Akt1/2 deficient B cell’s capacity to generate the BR3 substrate p100, a classical 
NFκB target downstream of the BCR, would more thoroughly examine the role of 
Akt in BCR-BR3 cross-talk.  Given the inability of Akt1/2 deficient progenitors to 
compete with wild-type cells, one might expect p100 generation, while not 
absent, could be decreased in response to tonic BCR signals.  This experiment 
 101 
will help elucidate the mechanism by which Akt1/2 deficient B cells fail to 
compete and survive when matched with wild-type cells.  Collectively, our results 
demonstrate that Akt is critical for competitive fitness, but this requirement is 
most likely independent of direct BR3 receptor pathway activity.   
 A final thought on p100 generation in peripheral B cell populations.  The 
capacity of the MZ B cell population to generate p100 in tonic or BCR cross-
linking studies remains unexplored.  A central question to the FOL vs MZ B cell 
fate decision is the role of BCR signal strength.  It is known that MZ B cells are 
more dependent on Blys than FOL B cells (Thien, Phan et al. 2004).  Whether 
this enhanced requirement reflects too much or too little p100 generation is 
unknown, but it is interesting to note that p100 is a target of the classical NFκB 
pathway.  As such p100 levels are in part dictated by p50.  MZ B cell 
development is blocked in the absence of p50 (Moran, Cariappa et al. 2007).  
Furthermore, Notch signaling is required for MZ B cell generation and Notch was 
recently shown to stabilize p50 levels (Shin, Minter et al. 2006; Moran, Cariappa 
et al. 2007).  Does this imply that Notch and the BCR communicate to generate a 
specified level of p100 such that BR3 can mediate processing and eventual 
transcription of Bcl-xL and Pim2?  This could be tested by first examining the 
capacity of MZ B cells to generate p100 downstream of BCR cross-linking, this 
experiment may require use of a Bcl-xL transgenic mouse as MZ B cells undergo 
apoptosis in response to BCR oligomerization.  If p100 is generated, the extent of 
p100 generation should be examined in MZ B cells co-cultured with OP9 stromal 
cells expressing the Notch ligand DL1 by both western and qRT-PCR. 
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5.4 Notch independent functions of the γ-secretase complex in BCR 
 mediated proliferation. 
 
 Previous observations demonstrated a synergy between Notch-DL1 and 
BCR signaling that resulted in enhanced proliferative and isotype switching 
responses (Thomas, Calamito et al. 2007).  These experiments forced Notch 
signaling upon B cells by co-culturing them with OP9- stromal cells engineered to 
express the Notch ligand DL1.  Interestingly, DL1 mRNA is expressed 
intrinsically on splenic B cells (Hozumi, Negishi et al. 2004).  This observation 
raised questions regarding the role for B-cell restricted Notch ligand expression 
in BCR mediated activation.  To inhibit Notch signaling, I cultured FOL B cells in 
the presence of GSI or vehicle control.  As described in the introduction, GSIs 
block the enzymatic activity of γ-secretase, which is required for Notch pathway 
activation.  These experiments showed that GSI greatly diminished the ability of 
FOL B cells to proliferate in response to antigen receptor stimulation  (Fig 17).  
This effect was specific to the BCR, as stimulation through TLR4 via LPS did not 
perturb CFSE dilution. In addition, I also showed that GSI was not inherently 
toxic to B cells as various doses of GSI resulted in the same cell viability when 
compared to the vehicle control DMSO.  Furthermore, both a Bcl-xL transgene 
and retrovirus could not rescue proliferation in GSI treated B cells (data not 
shown).  Collectively these results suggested that the Notch pathway could not 
only enhance BCR mediated proliferation as per earlier published studies, but 
that Notch was essential to proliferation via the antigen receptor.  A second and 
distinct hypothesis was that the effect I observed was Notch independent.  This 
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was not unreasonable, as over 80 different substrates have been identified as 
targets of the γ-secretase complex.  To better understand the mechanism 
causing decreased proliferation in GSI treated cultures I decided to target the 
Notch pathway specifically.  To this end I employed a system in which a 
DNMAML construct could be induced upon pulsing with a cell permeate Tat-Cre, 
and it’s expression tracked/sorted via GFP.  An advantage of this system was 
that it allowed B cell development to occur in the presence of normal Notch 
signaling, negating any selective bias that could be introduced as a result of 
Notch signaling blockade.  As demonstrated in Figure 18 inhibition of canonical 
Notch signaling did not have an effect on BCR mediated proliferation across 
multiple doses of anti-IgM cross-linking antibody, suggesting that Notch signaling 
is not required for normal BCR mediated activation.  Furthermore, addition of GSI 
to DNMAML expressing or non-expressing cells could repress BCR mediated 
proliferation (Fig 18).   
 These data were compelling, but a concern was that even though I could 
track DNMAML expression by GFP and this level of expression was sufficient to 
block Notch signaling as required for MZ B cell development, it was possible that 
the level of DNMAML reached during the 16hr incubation period before sorting 
and subsequent three days in culture was insufficient to block Notch signaling.  
To address this concern I harvested FOL B cells from CD19Cre ROSA26 +/DNMAML 
mice, these FOL B cells develop in the presence of DNMAML and are at steady 
state.  Cells in this pool have a life span in excess of three months, thus I’m 
confident that FOL B cells from these mice express levels of DNMAML  sufficient 
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to block canonical Notch signaling.  Experiments examining proliferation in these 
cells resulted in the same conclusion as those experiments utilizing Tat-Cre; 
Notch signaling is not required for BCR driven proliferation.   
 Previous work performed and published from our lab showed that Notch 
could enhance BCR signals.  My current results do not refute this finding, as 
those studies described a function for Notch in the enhancement of proliferation, 
i.e. what Notch “can do”.  In contrast, the experiments in this thesis examine the 
requirement for Notch in BCR driven proliferation and concludes that Notch is 
dispensable for BCR mediated activation.  Furthermore, my work, for the first 
time in B cells, suggests that the γ-secretase complex has Notch independent 
functions in B cell activation. 
 A limitation of my experimental approach was that it hinged upon chemical 
inhibitor based studies that could have off target effects.  To address the γ-
secretase specific phenotype I generated mice with conditional deletion of both 
isoforms of the catalytic subunit of γ-secretase, Presenilin 1 and Presenilin 2.  
Conditional deletion by a B cell specific Cre was required for the PS1 floxed gene 
as conventional PS1 or PS1/2 DKO mice are embryonic lethal (Feng, Rampon et 
al. 2001).  To examine the B cell intrinsic effects of Presenilin deletion on BCR 
mediated activation I performed a mixing experiment in which PS1/2 DKO FOL B 
cells were co-cultured with congenic wild-type FOL B cells.  These experiments 
recapitulated the GSI studies demonstrating defective proliferation in response to 
BCR cross-linking in the absence of Presenilin proteins and demonstrate that the 
defect is indeed B cell intrinsic (Fig 19A/B).  During the course of my thesis work 
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Yagi et al published that proliferative responses to BCR stimulation were 
abnormal in the absence of both PS1 and PS2, but these authors did not show 
that the defect was cell intrinsic.  Furthermore, they concluded that Presenilin 
proteins were required for proliferation in response to LPS stimulation (Yagi, 
Giallourakis et al. 2008).  While my observations agree with the BCR mediated 
proliferation defects, I do not find that Presenilins are required for LPS 
responsiveness. I’d like to point out that these workers did not control for 
differences in splenic B cell subset composition in Presenilin-deficient and wild 
type control animals. Indeed, it is well established that MZ B cells are highly 
enriched for LPS-responsive cells (Oliver, Martin et al. 1997), and this population 
is absent from PS1/PS2 DKO B cell pools, presumable due to failed Notch2 
activation. In contrast all experiments assessing B cell activation herein 
employed positively selected CD23+ B cells, which are highly enriched for FOL B 
cells and lack MZ B cells. Therefore, previous data suggesting that LPS 
responsiveness in B cells requires Presenilins instead reflect differences in B cell 
subset composition among Presenilin-deficient and control splenocytes.  
 The BCR specific defects suggested that downstream signaling could be 
altered.  A large body of evidence in neurons implicated Presenilin proteins in 
calcium regulation (Cai, Lin et al. 2006; Tu, Nelson et al. 2006; Cheung, 
Shineman et al. 2008).  To gain a qualitative measure of signaling downstream of 
the BCR in the absence of Presenilins I examined calcium mobilization (Fig 21).  
These experiments collectively demonstrated that BCR signaling responses are 
decreased both in terms of magnitude and kinetics in the absence of Presenilin 
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proteins.  Experiments performed in calcium free media suggest that the defect 
localizes to the initial BCR signaling cascade, implying that BCR activation is 
suboptimal.  These defects are in agreement with observations made by Yagi et 
al showing that Syk phosphorylation is decreased immediately after BCR cross-
linking (Yagi, Giallourakis et al. 2008).  Presenilin proteins do have functions 
independent of their catalytic activity, therefore future experiments utilizing a 
catalytically dead Presenilin mutant must be performed to ascertain the 
requirement for enzymatic activity in normal calcium mobilization.   
 Previous studies, some using GSI, concluded that Notch was a critical 
factor in the Th1 vs Th2 decision (Minter, Turley et al. 2005; Tu, Fang et al. 2005; 
Fang, Yashiro-Ohtani et al. 2007).  My results justify reexamination of this 
conclusion, as Minter et al may have been observing a Notch independent 
function of the inhibition of the γ-secretase complex.  My results demonstrate that 
further understanding of the γ-secretase complex is warranted as off target 
effects may be more severe than anticipated.  
 
5.5 Requirement for Presenilin in B1a B cell development and BCR 
repertoire formation 
 Mutations or deletion of proteins that strengthen BCR signaling, such as 
Btk, often coincide with defective calcium mobilization and a block B1 B cell 
development (Khan, Alt et al. 1995; Takata and Kurosaki 1996).  Therefore, I 
evaluated the peripheral B compartment of PS1/2 deficient mice and discovered 
a severe block in the generation of B1a B cells and overall decrease in the B1 
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compartment (Fig 23A).  Furthermore, loss of a single isoform of PS1 or PS2 
resulted in a similar albeit less dramatic decrease in the B1 pool.  I also noted 
that CD19+/Cre Rosa26 +/DNMAML mice do not show a defect in B1 B cell 
development (Fig 23B), again demonstrating that the effect is Notch 
independent.  These data, combined with the proliferation and calcium defects 
characterized above, imply that Presenilins function to optimize BCR signaling 
and potentially promote the selection of B1a and to a lesser extent B1b B cells.   
 An alternative explanation is that B1 B cell generation is normal in the 
absence of Presenilin proteins, but that the maintenance of this subset is 
defective, perhaps through defective self-renewal.  Future experiments will 
examine the B1 compartment in young mice to determine if B1 B cells are 
present at this early stage.  This is a critical experiment in that my current data 
only supports the hypothesis that abnormal BCR signaling is responsible for 
generating B1a cells, the possibility remains that altered self-renewal is the 
defect. 
Additional support for a Presenilin dependent function in BCR signaling 
and B cell development came from examination of the BCR repertoire as 
measured by λ frequencies.  As shown in Figure 24 of PS1 and PS2 resulted in 
decreased frequencies of λ bearing cells.  Furthermore, this effect was also 
observed in single knockouts.  As λ frequencies are thought to be representative 
of the extent of receptor editing (Nemazee 2006), these data suggest that 
receptor editing is diminished in the absence of Presenilin.  This may represent 
altered negative/positive selection as a result of abnormal BCR signaling.  
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Strikingly, studies from Laky et al showed that positive selection of 
developing T cells is compromised in PS1/PS2-deficient thymocytes, and led to 
models proposing that Notch activity regulates TCR signal strength during 
thymocyte development (Izon, Punt et al. 2001; Laky and Fowlkes 2007). 
However, in combining these observations with my data, it suggests that many of 
these effects may instead reflect Notch-independent functions for Presenilins. 
Therefore, whereas my results do not minimize the importance of Notch signaling 
in T and B cell development and function, they emphasize the need to 
understand the additional roles played by Presenilins in the immune system.   
5.6 Concluding remarks 
 My work shows that Akt1, Akt2 and Presenilins are critical factors in the 
generation of positively selected subsets, the peripheral BCR repertoire and BCR 
driven proliferation (Fig 27).  My data combined with observations from other 
labs suggests that these molecules are critical targets of BCR signaling, and may 
serve to strengthen antigen receptor signals.  An unanswered but important 
question is how CD19 and the BCR converge on Akt to drive the B1 and MZ fate.  
The data presented in this thesis suggests that survival and metabolism are not 
solely responsible for the block in the generation of these subsets.  For Presenilin 
a clear question that needs to be addressed is whether the defects observed in B 
cell development depend upon the catalytic activity of the γ-secretase complex, 
and if so what is the substrate (Fig 27)?  It would also be advantageous to 
generate mice deficient in Akt or Presenilins harboring Ig heavy chains such as 
M167 or 81x with idiotypes that drive defined cell fates within the B-lineage, 
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studies such as these will more precisely determine the role of these molecules 
in negative and positive selection.   
 Some twenty years ago Herzenberg and colleagues proposed the idea of 
a “layered immune system” in which the evolutionary most primitive cellular 
subsets would arise first.  From this foundation additional layers could be built 
increasing in complexity and providing survival and reproductive advantage to 
the organism (Herzenberg 1989).  In relation to B cell biology, B1 and MZ B cells 
with their “innate-like” T- cell independent functions may serve as the foundation 
of the humoral immune response.  From this foundation, the more complex T-
dependent, germinal center reactions dominated by FOL B cells evolved.  The 
biochemical pathways utilized by this evolutionary process are poorly 
understood.  Examination of previously published data and the work presented 
within this thesis demonstrates that though B1 and MZ cells may function in a 
more primitive way, the developmental requirements of these cells may be more 
complex than that of FOL B cells.  This implies that evolution favored “relaxing”  
positive selection standards to increase the diversity of antigens recognized and 
enlarge the overall B cell repertoire.   
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Figure 27.  Akt and presenilin promote BCR signaling and support generation of innate-
like B cell populations.  B cells deficient in Akt1/2 are phenotypically very similar to CD19 or 
PI-3K loss of function cells.  These observations suggest that Akt is a required downstream 
target of these molecules in the generation of the normal peripheral B cell pool.  Presenilins 
while required to generate MZ in a Notch dependent manner, also play critical Notch 
independent functions downstream of the BCR in the development of B1 B cells and BCR 
repertoire formation.  Collectively, Akt1/2 and Presenilins are important molecules in the 
generation and propagation of signals derived from the BCR and thus play a critical role in the 
formation of the humoral arm of the immune system. 
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Appendix Figure 1:  Early B cell development is normal in the absence of Akt1 or 
Akt2. (A) Representative flow cytometric analysis of BM cells from wild-type (top) 
Akt1+/+ (middle) Akt2-/- (bottom). The left-most plots are gated on viable donor-derived 
(DAPI-) cells. Numbers in plots indicate the frequency of events in the indicated gate as 
a function of the indicated parent population. Pro-B, CD43+ B220+ CD19+ AA4+; pre-B, 
CD43low B220+ IgM- AA4+; immature B, CD43- B220+ IgM+ AA4+; mature B, CD43- 
B220+ IgM+ AA4-. 
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Appendix Figure 2:  MZ B cell development is intact with loss of a single isoform 
of Akt1 or Akt2. Representative analysis of splenocytes from wild-type (top), Akt1-/- 
(middle), or Akt2-/- (bottom) mice. Viable donor-derived cells were gated as in Figure 1. 
Numbers in plots show the frequency of events as a function of the indicated parent 
gate. 
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